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ABSTRACT 
 
Christina Dawn Williams 
The association between dietary factors and risk of rectal cancer  
in African Americans and Whites 
(Under the direction of Jessie Satia, PhD, MPH) 
 
 
 
 Colorectal cancer (CRC), a commonly diagnosed malignancy in the U.S., refers to 
cancers of the colon and rectum. African-Americans have the highest incidence and mortality 
rates for CRC; many reasons for this disparity remain unknown.  Diet is involved in the 
etiology of CRC.  There is an abundance of literature on diet and CRC or colon cancer, while 
evidence is limited on the role of diet in rectal cancer specifically.  This dissertation 
addresses these issues by examining the relationship between dietary factors and rectal 
cancer risk, and determining if these associations differ between whites and African-
Americans. 
 We used the North Carolina Colon Cancer Study-Phase II, which included 945 rectal 
cancer cases (including sigmoid and rectosigmoid) and 959 controls.  The Diet History 
Questionnaire was used to assess dietary intake, and we examined the following dietary 
factors: macronutrients, micronutrients, food groups, and dietary patterns. 
 For macronutrients, we observed no association between fat intake in whites or 
African-Americans; only a possible risk reduction in African-Americans with high intake of 
polyunsaturated fatty acids.  In whites, protein (% energy) was associated with lower rectal 
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cancer risk.  In regards to the micronutrients, statistically significant inverse associations 
were observed in whites for most micronutrients, but only for selenium in African-
Americans.  Interestingly, micronutrient intake from dietary supplements did not provide 
additional risk reduction.  Regarding food groups, non-whole grains and white potatoes 
appeared to elevate rectal cancer risk in whites, while fruits, vegetables, dairy, fish, and 
poultry were inversely related to risk.  In African-Americans, high fruit intake was positively 
associated with risk for rectal cancer.  We identified three dietary patterns in whites and 
African-Americans.  The High fat/Meat/Potatoes pattern was similar in both race groups, and 
associated with elevated risk in whites. 
 This work adds to the literature on the relationship between diet and rectal cancer, 
and suggests that these associations differ by race.  It also provides information on the 
epidemiology of rectal cancer in African-Americans, for which evidence is lacking.  Rectal 
cancer is preventable, partially by dietary modifications; therefore, it is necessary to examine 
the role of diet in the etiology of rectal cancer, especially in large racially diverse samples. 
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 I. Introduction 
A. Background 
Colorectal cancer (cancer of the colon and rectum) is the fourth most common cancer 
among U.S. men and women. It is widely accepted that diet is involved in the etiology of 
colon and rectal cancer.  Numerous mechanisms have been proposed to explain how 
components of the diet may play a role in colon and rectal cancer development and 
progression.  In fact, diet is one of the strongest environmental risk factors for colon cancer.  
However, few studies have investigated the relationship between diet and rectal cancer alone. 
Therefore, the impact of diet on the risk of rectal cancer specifically is less clear.  There are 
known differences between colon and rectal cancer with respect to tumor development and 
progression, recurrence, and survival, but little attention has been given to differences in 
dietary risk factors.  Examining rectal cancer as a separate entity, and comparing the 
associated dietary risk factors to those for colon cancer, is essential to determining the extent 
of the similarities and differences between these two cancers. 
There are more cases of colorectal cancer, as well as the highest mortality rate, among 
African-Americans than any other U.S. race/ethnic group. Reasons for this disparity are 
largely unknown.   There is evidence that dietary intake differs between whites and African 
Americans; therefore, it is important to identify dietary factors that may contribute to the 
racial disparity in colon and rectal cancers.  Virtually no studies have included an adequate 
number of African-Americans and examined rectal cancer risk in this particular race/ethnic 
group.  
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This work provides information on possible racial differences in dietary intake and 
risk of developing rectal cancer.  To address the goals of this study, we used data from the 
North Carolina Colon Cancer Study-Phase II. This is a population-based case-control study 
of rectal cancer (including sigmoid and rectosigmoid), in which African-Americans were 
over-sampled.  We compared mean dietary intakes between African Americans and whites 
and used multivariate analyses to assess the relationship between numerous dietary factors 
and rectal cancer risk.   
 
B. Research aims 
 
The overall goal of this project was to assess the relationship between diet and the risk of 
rectal cancer among African-Americans and whites. This research addresses gaps in the 
literature by providing valuable information on the etiology of rectal cancer as it relates to 
diet, rectal cancer risk in African Americans, and how dietary intake may contribute to racial 
differences in risk. 
 
The specific aims of this research were to: 
 
1. Determine the association of nutrients (macronutrients: fat, protein; antioxidant 
micronutrients: vitamin C, vitamin E, beta-carotene, selenium; DNA methylation-
related micronutrients: folate, vitamin B6, vitamin B12) with rectal cancer risk in 
African Americans and whites.  
  
 Hypothesis: The macronutrients fat and protein are associated with elevated risk 
            of rectal cancer, while micronutrients are associated with reduced risk; however,  
            the magnitude of these associations differ by race. 
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2. Determine the association between food groups and rectal cancer risk in African       
Americans and whites. 
 
 Hypothesis: Food groups such as fruits and vegetables lower rectal cancer risk,  
            while food groups such as red meat elevate risk; there are racial differences in the  
            association between food groups and risk of rectal cancer.   
 
3. Determine the association between dietary patterns and risk of rectal cancer risk  
      in African Americans and whites. 
 Hypothesis: Dietary patterns, and their relationship with rectal cancer risk, differ 
 between African Americans and whites. 
 
 II. Literature Review 
A.  Scope of the problem 
 Colorectal cancer (CRC) is the fourth most common cancer in the US and worldwide 
and the second leading cause of cancer-related deaths (1).  It is estimated that in 2008 there 
will be 108,070 colon cancer cases and 40,740 rectal cancer cases, and colon and rectal 
cancers together would result in approximately 49,960 deaths. Here in North Carolina, the 
expected number of incident colorectal cancer cases and deaths in 2008 are 4,380 and 1,400, 
respectively (1). In general, rectal cancers account for approximately 30 percent of all 
colorectal cancers.  Colon and rectal cancers arise from a combination of genetic and 
environmental factors (2).  Established CRC risk factors include age, family history of CRC, 
history of polyps, and inflammatory bowel diseases such as Crohn’s disease and ulcerative 
colitis. Some environmental risk factors include physical inactivity, smoking, obesity, and 
diet (2). Given that colorectal cancer is potentially one of the most preventable malignancies, 
it is necessary to identify factors that contribute to their development, especially modifiable 
risk factors that could aid in prevention, such as diet. 
 
B. Diet and colorectal cancer 
 It is accepted that diet is involved in the etiology of CRC and is considered a strong 
risk factor for colon cancer (3).  Epidemiologic studies suggest that CRC is susceptible to 
modification by dietary factors.  For example, Slattery, et al suggested that about 12% of 
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colon cancers can be attributed to consumption of a Western-style diet, which is 
characterized as one high in meat, refined grains, and sugar and low intake of vegetables and 
fiber (4).  It has been estimated that more than 70% of colon cancers could be prevented 
through diet and lifestyle modifications , and that a third of all cancers could be prevented by 
diet alone (5).  The World Cancer Research Fund/American Institute for Cancer Research 
(WCRF/AICR) provides dietary recommendations for cancer prevention, based on 
epidemiological evidence and recommendations for preventing other chronic diseases (3). 
Some of these recommendations include limiting consumption of energy-dense foods, eating 
mostly foods of plant origin, limiting intake of red meat and avoiding processed meat, and 
limiting alcoholic drinks. Numerous mechanisms have been proposed regarding how these 
dietary factors may contribute to the development of colorectal cancer. 
 
1. Macronutrients 
 Fat, carbohydrate, and protein are considered macronutrients because they are 
relatively large molecules (6).  In general, the evidence is not consistent regarding the 
association between fat and carbohydrate intake and CRC risk, most likely due to the many 
sub-components of these two macronutrients. Although there are different types of fats (e.g. 
saturated and unsaturated), overall animal fat intake is associated with increased risk of CRC 
(3). Animal models have helped elucidate the effect of fat on colon cancer, suggesting that 
specific types of fat may be important determinants of risk (7).  The most compelling 
explanation is that dietary fat increases production of bile acids which promote tumorigenesis 
and proliferation, and that free fatty acid damages the intestinal epithelium (8). The effect of 
carbohydrates is often examined separately as fiber and non-fiber (i.e. effective 
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carbohydrate) components.  Refined carbohydrates can lead to increased intestinal absorption 
of glucose into the blood, resulting in hyperinsulinemia.  This in turn affects insulin-like 
growth factors that promote proliferation of colorectal cancer (9). Although there has been 
conflicting evidence regarding the association between fiber intake and risk of CRC, it is 
likely that fiber could reduce risk by diluting fecal content of dietary components, decreasing 
transit time of feces through the bowel, increasing stool weight, lowering intestinal pH, and 
producing short chain fatty acids that can induce apoptosis and cell cycle arrest (10).  There 
is no available epidemiological evidence that overall protein intake increases CRC risk, but it 
has been proposed that protein degradation results in amino acids that breakdown further into 
ammonia, which can be carcinogenic (11). Other potentially toxic components of protein 
degradation include phenolic compounds, amines, and N-nitroso compounds. However, this 
does not seem to be a well-accepted mechanism. Studies usually focus on meat, which is 
high in protein, as opposed to overall protein intake.   
 
2. Micronutrients 
 The micronutrients are vitamins and minerals, and are required in much smaller 
quantities than macronutrients.  There are a number of mechanisms to explain the potential 
role of micronutrients in CRC development, all of which suggest that micronutrients reduce 
the risk of CRC.  The antioxidant properties of many of these micronutrients (e.g. vitamin C, 
vitamin E, selenium, and carotenoids such as beta-carotene) are credited for their role in risk 
reduction (12-14).  Antioxidants scavenge free radicals and reactive oxygen molecules, 
protecting cells against oxidation damage, and vitamins C and E also protect against lipid 
peroxidation (15).  Abberrant DNA methylation patterns are commonly seen in colorectal 
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tumors (16); therefore, another potentially protective mechanism relates to nutrients involved 
in modulating DNA synthesis, repair, and methylation (13, 17). These nutrients include 
folate, vitamin B6, vitamin B12, and methionine.  It has been suggested that calcium may 
reduce CRC risk by inducing apoptosis and binding bile and free fatty acids (12, 14), 
whereas both calcium and vitamin D may reduce epithelial cell proliferation (18). It is 
important to note that many of these micronutrients have multiple biological properties that 
can impact colon and rectal cancer development.  For example, carotenoids are also known to 
effect cell growth regulation, modulate gene expression, and possibly enhance the immune 
response, thereby preventing CRC development (19).  Nutrients such as lycopene and 
selenium also have anti-inflammatory properties that help reduce risk of inflammatory 
illnesses such as inflammatory bowel disease (e.g. ulcerative colitis), which is a predisposing 
risk factor for CRC.  
 The associations of micronutrients with colon and CRC cancer risk have been 
extensively studied in large epidemiological studies such as the Nurses Health Study and 
Health Professionals Follow-Up Study (17, 20), and the Cancer Prevention Study II (21). 
Most evidence has confirmed the hypotheses of risk reduction due to adequate micronutrient 
intake.  Results from clinical trials, however, question the proposed protective effect of 
micronutrients. For example, the Aspirin/Folate Polyp Prevention Study did not demonstrate 
a protective effect of folate on colorectal adenomas, while the Women’s Antioxidant 
Cardiovascular Study found no effect of vitamins C and E and beta-carotene on CRC risk 
(22). 
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3. Food groups 
 The United States Department of Agriculture (USDA) provides dietary 
recommendations in regards to the types and amounts of food to consume daily.  The five 
primary food groups according to the food guide pyramid are grains, fruit, vegetables, milk 
(formerly referred to as dairy), and meat (23).  The grains food group consists of whole 
grains (e.g whole wheat bread, brown rice, oatmeal) and refined grains (e.g. white bread, 
white rice, most cereals). Consumption of whole grain foods are hypothesized to lower 
cancer risk due to their high content of antioxidants, fiber, and certain phytochemicals (24). 
Dairy products are a diverse food group that consists of factors that may increase CRC risk 
(e.g. high-saturated fat) (25), as well as high calcium and vitamin D that may reduce risk 
(26). It is suggested that low-fat dairy products, in general, have beneficial effects (27).  
 Of all associations of diet and colorectal cancer, fruit and vegetable intake and meat 
consumption are the most commonly investigated food groups.  Fruits and vegetables may 
protect against colorectal cancer risk through their anti-carcinogenic components such as 
antioxidants, folate, flavonoids, organosulfides, isothiocyanates (28). Some of these nutrients 
that deactivate carcinogens may also act to prevent chromosomal instability, which is 
considered a precursor to colorectal tumor development (29). Fiber from fruits and 
vegetables may decrease transit time, lower pH, and produce potentially anti-carcinogenic 
short-chain fatty acids (28).  However, studies on fruit and vegetable consumption and 
colorectal cancer have been inconsistent, with a recent pooled analysis of 14 cohort studies 
showing no protective effect (29). 
 Several large prospective studies (30, 31), as well as meta-analyses of cohort and 
case-control studies (32, 33) have shown increased consumption of red and processed meat to 
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correlate with elevated colorectal cancer risk, yet a protective effect of fish and poultry.   
Several hypotheses have been developed to explain these relationships.  One hypothesis is 
that the fat component of red meat increases bile acid excretion and this product can function 
in tumor development and cell proliferation in the colonic mucosa (34).  Other hypotheses 
relate to the production of N-nitroso compounds found in processed meat that can induce the 
formation of DNA adducts in cells in the colon, as well as the potentially carcinogenic 
heterocyclic amines and polycyclic aromatic hydrocarbons produced by cooking meats at 
high temperatures. The omega-3 fatty acid content in fish is thought to inhibit tumor growth 
and reduce the production of eicosanoids that cause inflammation (35).   
 
4. Dietary Patterns 
Most research concerning diet and colorectal cancer has focused on individual 
nutrients and foods, as previously illustrated. Few published studies have examined dietary 
patterns which take into account the synergistic effect of foods and nutrients, since foods and 
nutrients are not consumed in isolation.  These eating patterns also reflect genetic, cultural, 
environmental, social, health, and economic influences of eating behavior (36).  Dietary 
patterns may be useful in understanding disease etiology when there is conflicting evidence 
for diet associations; such is the case for some nutrients and colorectal cancer.  A typical 
“Western” dietary pattern is energy dense and consists of high intakes of meat, refined 
grains, potatoes, and sugar-containing foods, and less fruits and vegetables.  This eating 
pattern has emerged most frequently from analyses of dietary patterns and colorectal cancer 
risk.  Some studies have shown the “Western” dietary pattern to be positively associated with 
colorectal cancer (37-39), while others showed inconclusive results regarding eating patterns 
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and CRC (40, 41).  Other commonly observed patterns include a “vegetable”, “prudent”, and 
the “healthy” pattern, all of which are inversely related to CRC risk (37, 39, 41). These 
dietary patterns generally consist of high intakes of fruits and vegetables, fish and poultry, 
whole-grain products, and low-fat dairy products.  In general, dietary patterns may be more 
easily translated into dietary recommendations for colorectal cancer prevention. 
 
 
C. Rationale for examining diet and rectal cancer 
 There has been debate whether colon and rectal cancers should be considered a single 
entity.  These two tumor types are usually combined in diagnoses, as well as epidemiological 
studies, because they have the same precancerous lesion (i.e. polyp), similar mode of spread, 
some shared etiology, and of course, anatomical proximity (42). Furthermore, these two 
carcinomas are often grouped together because the boundary between the colon and rectum is 
not always clearly delineated (43), making it difficult to determine the exact location of the 
tumor. However, advances in the diagnosis and staging for rectal cancer (44), and the 
increasing variety of treatment options have helped to distinguish between tumor 
development processes for colon and rectal cancers (45). The main drawback of considering 
colon and rectal cancers as a single entity is that possible differences in epidemiological 
characteristics are not identifiable.  One study pointed out that there is less geographical 
variation of rectal cancer, as opposed to colon cancer, and that rectal cancers may be less 
susceptible to environmental influences than colon cancer (46).  Furthermore, there are 
differences between colon and rectal cancer that warrant examining the two carcinomas 
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separately, and comparing their epidemiological risk factors.  There are several reasons why 
dietary risk factors, in particular, may differentially affect the colon and rectum. 
 
1. Molecular differences 
 Colon and rectal cancers develop from a combination of genetic and environmental 
factors. Commonly mutated genes involved in the carcinogenic process include adenomatous 
polyposis coli (47), Kirsten-ras (k-ras), and p53 (12).  The APC and p53 genes are tumor 
suppressor genes whereas k-ras is an oncogene.  Approximately 80% of sporadic colorectal 
tumors have mutations in the APC gene, 30-50% of colorectal adenomas and carcinomas 
have k-ras mutations, and the p53 gene is mutated in up to 70% of colorectal cancers (48).  
Of the few studies that have examined biological differences, it has been suggested that there 
are different mechanisms of oncogenesis for colon and rectal carcinomas (49). There is 
evidence that k-ras and APC mutations are more common in colon tumors than rectal tumors 
(42, 48).   On the other hand, mutations in the p53 gene are more frequent in rectal tumors 
(48, 49).  It is suggested that the different bacterial flora in the rectum may alter the contact 
between potential carcinogens and lead to increased mutations of p53 (49).   Regardless of 
the specific genes involved, the number of mutation in colon tumors is significantly higher 
than those in rectal tumors (42).  Components of the diet may interact with these commonly 
mutated genes in the process of colon and rectal cancer development and progression. 
 
2. Differences in risk factors for colon and rectal cancer 
 Statistical analyses with the outcome of colorectal cancer ignore the possibility of 
heterogeneity between colon and rectal cancer. Due to the different mechanisms by which 
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colon and rectal carcinomas may develop and other notable distinctions, it may be 
inappropriate to assume homogeneity, and established risk factors may for colon cancer may 
not apply (or be relevant to) rectal cancer.  Some studies have made the attempt to 
distinguish between predictors for colon versus rectal cancer.  It has been shown that obesity, 
for example, is a significant predictor of colon cancer, but not rectal cancer (50-52).  
Likewise studies have consistently shown physical activity to be associated with reduced risk 
for colon cancer, but no protective effect against rectal cancer has been found to date (53). A 
possible explanation for this is that insulin sensitivity improves with more physical activity, 
and the colon is more susceptible to insulin’s effects (54).  Wei et.al observed that family 
history of colorectal cancer correlated with a stronger risk for colon cancer than rectal cancer, 
while smoking was more strongly associated with rectal cancer (55).  Based on the different 
methods by which colon and rectal tumors arise, as well as the observed differences in non-
dietary risk factors, it is hypothesized that dietary factors may also differentially affect risk of 
colon and rectal cancers. 
 
3. Hypotheses for differential effects of diet on colon vs. rectum 
 It is proposed that dietary factors may differentially affect risk of colon and rectal 
cancer for several reasons.  In addition to the fact that the colon and rectum arise from 
different embryonic tissue as well as have different molecular aspects of tumor development, 
they also serve different functions.  The colon functions to absorb water and minerals from 
food and transport them into the bloodstream while the rectum serves as a collection site and 
stores fecal matter until it is eliminated from the body. The presence of different mutations 
may result in different diet-gene interactions in colon and rectal cancer development.  
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Because the rectum is usually empty until wastes are ready to be eliminated from the body, 
there may be a shorter duration of exposure to potentially carcinogenic dietary components.  
The different pH levels (55) and bacterial composition (56) of the colon and rectum may also 
affect their susceptibility to environmental factors such as diet.   
 
 
D. Racial differences 
In addition to differences between the colon and rectum, there are racial differences in 
dietary behaviors and colorectal cancer outcomes. 
 
1. Colorectal cancer outcomes 
 Colorectal cancer incidence and mortality differ appreciably by race, for many 
reasons which remain unknown. Specifically, African-Americans have the highest rates of 
colorectal cancer among all US racial/ethnic groups (1).  However, when examining the 
statistics for colon and rectal cancer separately, it is obvious that the disparity is much greater 
for colon than rectal cancer. Between 1999 and 2004, colon cancer incidence rates for 
African-Americans and Whites were 44.3 and 35.1 per 100,000 persons, respectively; 
corresponding rates for rectal cancer were 13.1 and 13.3. Colon cancer mortality rates for 
African-Americans and Whites were 21.5 and 14.6, respectively, while corresponding rates 
for rectal cancer were 3.3 and 2.9 (57). So for rectal carcinomas specifically, incidence is 
higher among Whites while mortality is greater among African-Americans. African-
Americans were also less likely to have localized disease and had increased rates of proximal 
colon carcinoma (58), and more likely to be diagnosed with advanced stage colorectal cancer 
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(i.e. Stage III and Stage IV).  Some of the overall disparity can be explained by genetic, 
socioeconomic, and healthcare access differences (59); however, lifestyle factors such as diet 
may also play a role. 
 
2. Dietary behaviors 
 Studies have indicated that dietary behaviors differ widely by race and ethnicity (60).  
Whites have been shown to consume more fruits and dairy products than African-Americans 
(61), and use lower-fat alternatives in their food preparation (62).  African-American women 
were shown to have significantly lower intakes of vitamin D, vitamin E, folate, and vitamin 
B-6 compared to White women, mostly due to the increased supplement use among Whites 
(63).  According to data from the National Health and Nutrition Examination Surveys, 
African-American men and women reported lower intakes of vegetables, potassium, and 
calcium than their White counterparts (64). Similarly, African-American children were at 
increased risk of vitamin A, vitamin E, calcium, iron and zinc deficiency based on the UDSA 
Continuing Survey of Food Intakes by Individuals (65).  In their assessment of dietary intake 
trends among African-Americans and Whites, Kant, et al suggests that previous dietary risk 
factors for African-Americans have not improved (64).   
 
3. Influence of diet on cancer risk  
 Furthermore, these dietary behaviors have also been observed to differentially affect 
risk of disease among these two race subgroups.  For example, increased consumption of 
high animal-fat foods was related to prostate cancer among African-Americans, but not 
Whites (66).  African-American men with indicators of poor vitamin D status had an 
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appreciably higher risk of cancer incidence and mortality, especially for cancers of the 
digestive system (67).  Also, increased alcohol consumption and tobacco use correlated with 
a 17-fold risk increase of oral cancer among African-Americans compared to a 9-fold 
increase among Whites (68).  Other findings indicate that dietary intake differences may 
contribute to higher mortality rates of breast cancer among African-American women (69).  
Preliminary studies by Satia, et al showed that nutrient intake and associations with colon 
cancer differed by race (70-72). Given that dietary factors contribute to differences in risk 
among African-Americans and Whites for other cancer types, such differences may also exist 
for rectal cancer.  It is also important to note that genetic polymorphisms may also vary by 
race and contribute to differences in disease risk. Therefore, when possible, diet-gene 
interactions should be assessed. However, the genetic contribution to colon and rectal cancer 
risk is outside the scope of this research. 
 
E.  Limitations of current studies 
 While there is an abundance of evidence for the role of diet on risk of colon cancer 
and colorectal cancer, much fewer studies have examined the relationship between diet and 
rectal cancer.  Even the comprehensive review done by the World Cancer Research 
Fund/American Institute for Cancer Research stated that they had less evidence on risk 
factors for rectal cancer (3).  Of the studies that have attempted to examine epidemiologic 
risk factors by sub-sites of the colorectum, they often had very few rectal cancer cases, 
thereby limiting the statistical power to detect significant associations.  This study will help 
fill this gap in the literature by providing evidence for dietary risk factors for rectal cancer 
specifically in a large sample of rectal cancer cases and controls.  Furthermore, it will 
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provide information on rectal cancer in African Americans, for which the available literature 
is lacking, and how diet may contribute to racial differences in risk of rectal cancer.  
 
F. Summary and significance 
 Colon and rectal cancers are preventable, partially by dietary modifications.  To aid in 
the prevention of these cancers and elimination of the racial disparity, it is necessary to 
determine environmental and genetic factors that contribute to elevated risk for both tumor 
types in racially/ethnically diverse study samples.  Because there are few published 
epidemiological studies that solely focus on rectal cancer and associations with diet, and 
none that include adequate representation of African-Americans, this study aims to determine 
dietary factors associated with risk of rectal cancer and assess racial differences.  Currently, 
these relationships have not been examined in a racially heterogeneous population. This 
project contributes appreciably to the knowledge of the etiology of rectal cancer, especially 
in African-Americans, and provides possible explanations for racial disparities.  
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 III. Study Design and Methods 
A. Overview 
 This proposed study seeks to 1) determine the association between nutrients and risk 
of rectal cancer in whites and African Americans, 2) determine the association between food 
groups and risk of rectal cancer in whites and African Americans, and 3) determine the 
association between dietary patterns and risk of rectal cancer in whites and African 
Americans.  These aims were accomplished using data from the North Carolina Colon 
Cancer Study-Phase II (NCCCS- Phase II).  This population-based case-control study of 
rectal cancer (including sigmoid and rectosigmoid) was conducted between May 2001 and 
September 2006. One of the overall goals of the NCCCS-Phase II was to identify 
environmental and lifestyle risk factors for rectal cancer in African-Americans and whites; 
therefore the specific aims of this proposed research fits well into this broad objective. 
 
B. Study area and population 
Study area 
 The study area consists of 33 contiguous counties in the central and eastern portion of 
North Carolina.  These counties represent the major urban areas of the state, as well as large 
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segments of rural areas.  African-Americans make up about one-third of the population of 
these counties, and this area provides a good socioeconomic mix of African-Americans and 
Whites in order to make comparisons.  All 59 hospitals in the 33-county study area 
participated.  Border counties were intentionally excluded to limit the referral of patients to 
non-participating hospitals. 
 
Cases 
 Cases were identified using the rapid ascertainment system of the North Carolina 
Central Cancer Registry (CCR).  This system required hospitals in the 33 counties to forward 
pathology reports and identifying data for newly diagnosed cases to the North Carolina CCR 
staff in Raleigh, NC within one month of a case’s diagnosis. The CCR staff performed initial 
screening checks to determine if the case met the study eligibility requirements.  Eligible 
cases were forwarded to the NCCCS-Phase II study staff weekly. Case eligibility criteria 
included: 40-79 years of age (inclusive) at time of diagnosis, resided in one of the 33 target 
counties, African-American or White, and had a North Carolina driver’s license or 
identification card if under 65 (because controls under 65 were selected from Department of 
Motor Vehicle rosters). They also had to be proficient in English and able to complete an 
interview.  Cases had a diagnosis of rectal adenocarcinoma (including cancers of the sigmoid 
and rectosigmoid junction to increase the number of available subjects) between May 1, 2001 
and September 30, 2006.  All diagnoses were confirmed by the study pathologist using  
pathology slides and medical records. Cases were excluded if they had diagnoses of non-
invasive carcinoma, a previous diagnosis of colorectal cancer, or were deceased at time of 
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identification. Permission was obtained from each case’s primary physician before contacting 
them about study participation. 
 
Controls  
 Controls were selected from two sources: 1) North Carolina Division of Motor 
Vehicles (DMV) records for those under the age of 65; 2) Center for Medicaid and Medicare 
Services (CMS, formerly known as the Health Care Financing Administration) for those 65 
and older. The DMV and CMS have the most comprehensive databases of NC residents 
between the ages of 40 and 79. The DMV and CMS can provide a list of NC residents with a 
license or ID card and a list of Medicare recipients, respectively, to health researchers for 
studies that are likely to benefit citizens of NC.  All controls were 40-79 years of age, resided 
within the 33 target counties, had no previous diagnosis of colorectal cancer, African-
American or White, alive at time of selection and interview, and proficient in English and 
able to complete the interview.  The study team received lists of recruitable controls from the 
DMV and CMS, containing age, sex, ethnicity, as well as their contact information. Only a 
random sub-sample of eligible controls was randomized to recruitment. Control sampling and 
randomization to recruitment was done at the beginning of the study and at the midpoint of 
data collection, using updated lists. 
 
C. Sampling and recruitment 
 A randomized process was used to determine which cases and controls to contact 
regarding participation.  This randomized recruitment strategy was used to control for 
potential confounding by race, age, and sex, and to achieve a race ratio sufficient for 
statistical efficiency to assess interaction by race (1).  Cases were sampled to yield a 3:1 ratio 
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of Whites to African-Americans.  One particular benefit of randomized recruitment is that the 
main effect of the design variables (race, sex, age) can be estimated using maximum 
likelihood estimation in logistic models.  A main goal of the NCCCS-Phase II is to assess 
whether colon/rectal cancer risk indicators differ by race; therefore African-American cases 
and controls were over-sampled since the African-American population in North Carolina is 
only about 20%. 
  To implement randomized recruitment, estimates of the relative risks for the matched 
design variables were used to derive recruitment probabilities, which in turn affect the case 
and control distributions.  All eligible cases and control subjects were assigned a random 
number between 0 and 1, and this number was compared to the recruitment probability. If the 
random number was less than or equal to the recruitment probability, then the potential 
participant was recruited to participate in the study. As previously mentioned, a unique 
feature of this study was that African-American cases and controls were over-sampled. The 
recruitment probability for African-American cases was 1.0 (i.e. all were recruited) and 
African-American controls had higher recruitment probabilities than White controls. The 
overall population distribution of cases and controls is shown in Table 1.  
 
Table 1: Population distribution of the NCCCS-Phase II   
 Study sample 
 
    Cases                 Controls 
                 
Sampled 
Eligible 
Interviewed 
Analyzed 
Response rate* 
1831 2345 
1417 1827 
1057 1019 
945 959 
74%                       56% 
*response rate=number interviewed/number eligible 
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D. Data collection 
 Data were collected by trained nurse-interviewers during in-person interviews using 
two main questionnaires: the participant questionnaire and the diet questionnaire.  Interviews 
were conducted in participants’ homes or another convenient location, such as the local 
hospital or health department.   
 
1. Exposure assessment 
 Diet is the exposure of interest in this proposed research study.  The NCCCS-Phase II 
used a food frequency questionnaire (FFQ) that assessed portion size and frequency of 
consumption.  Food frequency questionnaires are thought be a practical tool for collecting 
dietary data in large epidemiological studies (2).  Compared to other methods such as the 24 
hour recall, the FFQ collects less detail regarding the foods consumed, cooking methods, and 
portion size. However, the FFQ is designed to assess usual dietary intake and the nutrient 
values obtained can be used to rank individuals based on their nutrient intakes (3). Therefore, 
it was a suitable dietary assessment tool for this study.   
 The FFQ used in the NCCCS-Phase II was the Diet History Questionnaire (DHQ). 
The DHQ was developed by the National Cancer Institute and its validity was assessed in 
racially diverse samples. The race/ethnicity distribution in the validation study by Thompson, 
et al was 79% White, 10% African American, 5% Latino, and 5% Other (4); the validation 
study done by Subar, et al. was 76% White, 14% African American, 4% Latino, and 6% 
Other (2). The DHQ is a cognitively-based FFQ and an extension of the NCI Block FFQ.  It 
has been shown that the cognitive improvements in the DHQ provide better measures of 
frequency than the Block FFQ (4), and have similar or higher correlations compared to the 
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Block FFQ (2). The DHQ consists of 124 separate food items and assesses the frequency of 
consumption and portion size consumed for each food item. In addition, it contains ten 
questions about the frequency and dose of dietary supplements used.   
 The questionnaire was administered by a nurse-interviewer and referred to 
participants’ food and beverage intake in the past 12 months to take into account seasonal 
variation in food consumption.  Cases were asked to estimate their usual intake 1 year prior 
to diagnosis, and controls were asked to estimate consumption 1 year prior to interview.  
Food and nutrient estimates were determined using the NCI’s Diet*calc analysis program 
which estimates intake based on reported frequency and serving size of each food item.    
 
2. Covariate assessment 
 The participant questionnaire collected data on many characteristics, and the 
following covariates were used in this study: 
 
Demographic characteristics 
 Demographic information that was collected included age, sex, race, and education 
(less than high School, high School or GED equivalent, some college, college or advanced 
degree), and annual household income.  
 
Lifestyle factors 
 Detailed information was collected regarding cigarette, cigar, and pipe smoking 
because smoking has been shown to increase risk for colorectal cancer (5). Smoking status 
was categorized as never smoker, former smoker, or current smoker. Information on 
subjects’ physical activity level (very hard, hard, moderate, light, sleeping/relaxing) for 
occupational and non-occupational activities was collected, as well as the amount of time 
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spent during typical work and non-work days in different activities during the one-year 
referent period.  Metabolic equivalent task minutes per day for each level of physical activity 
was categorized into quartiles and used to assess confounding by physical activity.   
 
Non-steroidal anti-inflammatory drug (NSAID) use 
 NSAID use was assessed because the literature supports a protective effect of regular 
use (3-4 times a week) of NSAIDs such as aspirin (6).  The questionnaire asked about 
prescription and non-prescription NSAIDs, including the frequency, duration, and use during 
the past five years.  NSAID use was categorized as regular (more than 15 times a month) and 
non-regular users (15 or less times a month).   
 
Family history of CRC 
 Participants indicated if there was a family history of colorectal cancer (yes/no).  The 
questionnaire asked for information on the vital status, current age or age at death, and 
history of cancer for all first-degree relatives. For those with a history of cancer, information 
was collected regarding the site and age at diagnosis. 
 
Anthropometric measurements 
 Study participants’ height and weight were measured by the interviewer to calculate 
their BMI (weight (kg)/height (m2)).  Their waist and hip circumference were also measured. 
Participants were asked to recall their weight 1 year and 5 years ago. Data from the NCCCS 
show that many cases lost weight, possibly as a consequence of their illness; therefore, BMI 
1 year ago was assessed as a potential confounder.  BMI was categorized as normal weight 
(18-24.9kg/m2), overweight (25-29.9 kg/m2) or obese (≥30 kg/m2) (7). 
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E. Statistical analyses 
 All analyses were performed using SAS software (8).  Descriptive statistics (means, 
standard deviations, and frequencies) were computed for all study variables by case-control 
status and race.  A 5% significance level was used for all statistical tests, and 95% confidence 
intervals were constructed. Table 2 shows all variables considered in this study. 
 
Table 2: Study variables 
Dietary exposures Outcome Covariates 
Macronutrients  
      Fat (saturated, monounsaturated, polyunsaturated) 
      Protein 
 
Micronutrients  
      Antioxidant nutrients 
           Vitamin C, Vitamin E, beta-carotene, selenium 
      DNA methylation-related nutrients 
           Folate, Vitamin B6, Vitamin B12 
 
Food groups 
      Grains, Dairy, Fruits, Vegetables, Meat, Other 
 
Dietary patterns 
Rectal cancer 
 
(including 
sigmoid and 
rectosigmoid 
cancers) 
Age 
Sex 
Race 
Education 
Income 
Smoking status 
Physical activity 
BMI  
NSAID use 
Family history of   
    CRC 
 
1. Aim 1: Determine the association of nutrients (macronutrients (fat, protein), antioxidant 
micronutrients (vitamin C, vitamin E, beta-carotene, selenium), and DNA methylation-
related micronutrients (folate, vitamin B6, vitamin B12)) with rectal cancer risk in African 
Americans and whites. 
 
a) Macronutrients 
 The goal of this sub-aim was to estimate the risk of rectal cancer associated with fat 
(total, saturated, monounsaturated, and polyunsaturated) and protein, as well as the percent of 
energy from fat and protein.  Descriptive statistics included means and standard deviations of 
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intake for each macronutrient among cases and controls.  The Wilcoxon rank sum procedure 
was used to determine if mean intake differed between cases and controls. 
 Logistic regression analyses were used to examine the relationship between 
macronutrients and rectal cancer risk. We categorized macronutrient intake into quartiles to 
reduce the impact of extreme values.  Cut-points for quartiles were based on the distribution 
among race-specific controls. Odds ratios were estimated by comparing each quartile to the 
lowest.  A test for linear trend was conducted by incorporating a variable containing the 
median levels observed for each quartile of macronutrient intake into a logistic regression 
model, and using the resulting p value to determine the presence/absence of a significant 
trend.  The tests for linear trend models were weighted by the inverse of the variance to 
account for the variance within each quartile.  Each macronutrient was analyzed in separate 
models, and all analyses were adjusted for potential confounders (see III.E.4b). 
 
b) Micronutrients 
 The goal of this sub-aim was to estimate the risk of rectal cancer associated with two 
categories of micronutrients based on their proposed mechanism of effect: antioxidant 
micronutrients (vitamin C, vitamin E, beta-carotene, selenium) and DNA methylation-related 
micronutrients (folate, vitamin B6, and vitamin B12).  Descriptive statistics included means 
and standard deviations of intake for each micronutrient among cases and controls.  The 
Wilcoxon rank sum test was used to determine if mean intake differed between cases and 
controls.  To assess racial differences in micronutrient intake, this test was also used to 
compare mean micronutrient intakes between White and African American controls. 
 Logistic regression analyses were used to determine the association of these 
micronutrients with rectal cancer risk.  The micronutrients were categorized into quartiles to 
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reduce the impact of extreme values.  Cut-points for quartiles of micronutrient intakes were 
based on the distribution among race-specific controls. Odds ratios were estimated by 
comparing each quartile to the lowest. A test for trend was conducted by incorporating a 
continuous variable representing the median levels observed for each quartile of 
micronutrient intake into a logistic regression model, and using the resulting p value to 
determine the presence/absence of a significant trend. These trend test models were weighted 
by the inverse of the quartile variances. The micronutrients were first examined in separate 
logistic regression models.  We then examined the effect of each micronutrient while 
adjusting for the other micronutrients in the same category to simulate the combined (and 
highly correlated) effect of these nutrients in food.  All analyses will be adjusted for potential 
confounders (see III.E.4b).  We performed these analyses with and without adjustment for 
fruits and vegetables, which are the primary food sources of these nutrients. 
 Since a large proportion of micronutrient intake comes from dietary supplements (9), 
these analyses were done for micronutrient intake from foods only, as well as total 
micronutrient intake from the combination of foods and supplements.  The Diet History 
Questionnaire included an additional ten questions on the frequency and dose of single 
vitamin/mineral supplement use as well as the use of multivitamins/minerals. 
 
2. Aim 2: Determine the association between food groups and rectal cancer risk in African 
Americans and whites 
 
 The goal of this aim was to estimate the risk of rectal cancer associated with food 
groups defined by the United States Department of Agriculture (USDA). The five main 
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USDA pyramid food groups are grains, fruits, vegetables, dairy, and meat. We examined 
total intake of these food groups and numerous sub-groups; therefore, our analysis was based 
on 29 food groups.  Descriptive statistics included means and standard deviations of intake 
for each food group among cases and controls.  The t-test procedure was used to determine if 
mean intake differs between cases and controls. 
 Logistic regression analyses were used to obtain odds ratios and 95% confidence 
intervals for the relationship between each food group and rectal cancer risk. These food 
groups were categorized into quartiles and the cut-points for these quartiles were based on 
the distribution among race-specific controls. Odds ratios were estimated by comparing each 
quartile to the lowest. A test for linear trend was conducted by incorporating a variable 
containing the median levels observed for each quartile of intake into a logistic regression 
model, and using the resulting p value to determine the presence/absence of a significant 
trend. These logistic regression models for the trend test were weighted by the inverse of the 
variance for the quartiles.  Each food group was analyzed in separate models, and all 
analyses were adjusted for potential confounders (see III.E.4b). 
 
3. Aim 3: Determine the association between dietary patterns and risk of rectal cancer risk in 
African Americans and whites 
 
 The goal of this aim was to create dietary patterns using control subjects who, we 
assume, represent the general population, and estimate the risk of rectal cancer associated 
with these dietary patterns. We created the dietary patterns separately for whites and African 
Americans to account for possible racial differences in consumption and correlations 
between food groups. The dietary patterns were based on the same food groups as in Aim 2, 
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with some exclusions.  The food group totals (i.e. total grains, total fruit, etc.) were excluded 
so the dietary patterns would be based on mutually exclusive food groups.  The organ meat 
and soy products were excluded and yogurt was combined with the milk group because there 
was a large percentage of non-consumers of organ meat, soy, and yogurt. Alcohol was also 
excluded because it may be a part of an overall behavior pattern and not just a dietary pattern.  
 There are several methods used to determine dietary patterns.  One of the data-driven 
methods is factor analysis (10).  Factor analysis reduces data into ‘factors’ based on 
correlations between foods and assigns factor scores for each factor.  Most studies using 
factor analysis have used the principal components analysis (PCA) method, which is used 
when variables are highly correlated, as is the case for most dietary data.  PCA reduces the 
number of observed variables to a smaller number of principal components that account for 
most of the variance of the observed variables. For this aim, we used the PCA method to 
identify dietary patterns among race-specific controls.  We retained factors with eigenvalues 
>1.0, which indicate that the factor describes more of the variability in the data than a single 
variable (11). We also assessed the scree plot and interpretability of the factors.  Based on 
these criteria, we extracted the factors to be used in subsequent analyses.  Factors were 
rotated using a varimax (orthogonal) rotation to obtain a more easily interpretable solution 
and uncorrelated factors.  The factor loading matrix illustrates how each food group 
correlated with each factor.  These factors represent the dietary patterns in the study sample. 
Once the dietary patterns were determined by PCA and labeled based on foods with high 
factor loadings, factor scores were obtained and applied to each observation, then used as the 
exposure variables in logistic regression models.   
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The relationship between factor scores and other dietary and lifestyle variables were 
analyzed using Pearson and Spearman correlations for continuous and categorical variables, 
respectively.  Partial Pearson correlations adjusted for total energy were obtained for all 
dietary variables.  Odds ratios and 95% confidence intervals for risk of rectal cancer for each 
dietary pattern was estimated using logistic regression analyses.  The linear trend test was 
done by incorporating the median factor scores for each quartile as a continuous variable in 
models, which were weighted by the inverse of the variance. All analyses were adjusted for 
potential confounders (see III.E.4b). 
 
4. Common statistical methods for all aims 
 There are several common statistical methods that were applied to all previous 
analyses.   
a) Effect modification 
 Effect measure modification by race was assessed in all analyses.  This was done 
using two methods.  One method involved using the Breslow-Day test for homogeneity to 
test the homogeneity of binary covariates across the two race categories.  The p value 
associated with the Breslow-Day statistic tests the null hypothesis that the covariates are 
constant across race strata.  The other method was the likelihood ratio test to compare logistic 
regression models with and without interaction terms. The likelihood ratio test helped 
determine whether the full model including the interaction terms, which allowed the model to 
depart from constancy, maximized the likelihood of the observed data better than the reduced 
model, which contained no interaction terms.  If these tests supported the constancy 
assumption, we still presented the results stratified by race.  Because data are lacking 
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regarding the epidemiology of rectal cancer in African-Americans, it is valuable to present 
the data separately by race and fill this gap in the literature. 
 There are different incidence and mortality rates for colon and rectal cancer for males 
and females. In addition, the literature suggests that sex modifies the effect of risk factors for 
colorectal cancer (12); therefore we assessed effect measure modification by sex.  
 
b) Confounding 
 To assess confounding, we conducted bivariate analyses of each potential confounder 
in a logistic regression model and covariate inclusion was based on a 10 percent or greater 
alteration in the parameter coefficient of continuous dietary variables.  All covariates that met 
this criterion were simultaneously included in a model, and a backwards stepwise procedure 
was done to obtain the final model.  This method is most useful when there are a large 
number of predictors, as was the case in these analyses. The potential confounding factors 
included age, sex, education, income, prior BMI, smoking status, physical activity, family 
history of CRC, and NSAID use. 
 All analyses were adjusted for total energy and other dietary variables where 
appropriate.  Absolute nutrient intake is a function of total energy intake and the composition 
of the diet (3). Therefore, most nutrients, especially macronutrients, are highly correlated 
with total energy intake.  It is necessary to adjust for total energy in diet-disease associations 
in order to distinguish the effects of a particular nutrient from that of total energy intake, 
which is mainly determined by body size and physical activity(13). 
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c) Offset term 
 All statistical analyses included an offset term to account for the sampling 
probabilities. This resulted in unbiased odds ratios and allowed estimation of the main effects 
for matching variables (14).  The offset term used in the analyses was based on the original 
age-sex-race strata from the rosters used to ascertain cases and controls.  It was necessary to 
include this term in all analyses because recruitment was conditioned on age, sex, and race, 
in addition to disease status; thus the odds ratios without the offset term would have been 
biased compared with a traditional design in which recruitment was conditioned on disease 
status alone.   
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 IV. Antioxidant and DNA methylation-related micronutrients and risk of rectal cancer 
 
A. Abstract 
 
Objective:  To investigate the relationship between antioxidant nutrients (vitamins C and E, 
β-carotene, selenium) and DNA methylation-related nutrients (folate, vitamins B6 and B12) 
and rectal cancer risk in whites and African Americans, and to examine intakes from food 
only versus total (food plus dietary supplements) intakes.  Methods: Data are from the North 
Carolina Colon Cancer Study-Phase II, a case-control study of 945 rectal cancer (including 
sigmoid and rectosigmoid junction) cases and 959 controls.  In-person interviews captured 
usual dietary intake (using the Diet History Questionnaire) and various covariates.  
Multivariate logistic regression was used to calculate odds ratios (OR) and 95% confidence 
intervals (95% CI).  Results: High intakes of all antioxidant nutrients were associated with 
reduced risk in whites, except total vitamin E intake. Only selenium had a statistically 
significant inverse association in African Americans (OR: 0.25, 95% CI 0.08-0.84). All DNA 
methylation-related nutrients had independent inverse associations with rectal cancer risk in 
whites; there were no statistically significant associations in African Americans.   
Supplements did not provide additional risk reduction beyond intakes from food.  
Conclusions: Our findings provide evidence that micronutrients may lower the risk of rectal 
cancer, and that optimal micronutrient intakes from food alone may be more beneficial than 
supplementation. 
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B.  Introduction 
 Colorectal cancer (CRC) is the third most common cancer in the U.S. (1) and results 
from a combination of genetic, epigenetic, and environmental factors (2, 3).  Diet is widely 
believed to play an important role in the development of CRC, and a number of dietary 
micronutrients have been associated with CRC risk (4-7). However, results in epidemiologic 
studies are often conflicting. Some observational studies have reported CRC risk reductions 
associated with micronutrient intake (4, 7), while clinical trials found null or positive 
associations (8, 9).  Therefore, an exploration of these associations driven by knowledge of 
mechanisms of action can be very informative.  Several biological mechanisms provide a 
theoretical link between micronutrients and reduced risk of CRC (10, 11) . 
Oxidative stress plays a major role in CRC development and progression (12, 13), 
and results from an excess production of free radicals or insufficient antioxidant defenses 
(14, 15).  Free radicals are unstable, highly reactive, oxygen-containing molecules that can 
cause tissue damage.  Therefore, the balance between free radicals and antioxidants is 
critical. Numerous dietary nutrients, such as vitamin C, vitamin E, carotenoids, and selenium, 
have antioxidant properties (11, 16).  Antioxidant nutrients protect against the damaging 
effects of free radicals, thereby reducing oxidative stress and ultimately preventing CRC.   
Another well-known process involved in colorectal carcinogenesis is DNA 
hypomethylation, which is consistently observed in colon neoplasms (3, 17).   
Hypomethylation is a result of low levels of S-adenosyl methionine (SAM), and the 
production of SAM depends on dietary factors such as folate, vitamin B6, and vitamin B12.  
The main role of folate is to provide one-carbon units in several reactions necessary for DNA 
methylation and synthesis, while vitamins B12 and B6 serve as cofactors in some of these 
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reactions (18).  Therefore, sustained low levels of these nutrients can lead to disturbances in 
DNA methylation, synthesis, and repair, thus influencing colorectal carcinogenesis. 
Despite the biological and mechanistic rationale for the hypothesis that these nutrients 
could reduce the risk of CRC development, epidemiological studies have yielded inconsistent 
results.  This may in part be due to different methods of diet assessment, or that few studies 
had complete data on both dietary and supplemental sources of these nutrients.   It is 
particularly important to include intakes from vitamin and mineral supplements, as they 
contribute appreciably to micronutrient intakes (19). Compared to colon cancer, evidence is 
limited regarding the association between these micronutrients and rectal cancer (4-7, 20-22), 
although it has been suggested that dietary risk factors may differ for these two carcinomas.  
Most published studies have had few rectal cases (5-7, 20, 22); none have reported on these 
associations in African Americans.   
In this report, we examined associations of total intake of selected micronutrients 
(from food only and food plus dietary supplements) with risk of rectal cancer among White 
and African American participants. Specifically, we evaluated the relationships between 
antioxidant nutrients (vitamin C, vitamin E, β-carotene, selenium) and DNA methylation-
related nutrients (folate, vitamin B6, vitamin B12) and the risk of rectal cancer in a 
population-based case-control study.  We chose these micronutrients based on a plausible 
biological rationale, and we further examine the combined effects of nutrients hypothesized 
to function in similar ways to affect rectal cancer. 
 
C.  Methods  
1. Study design and population 
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 Data were obtained from the North Carolina Colon Cancer Study-Phase II, which was 
conducted between May 2001 and September 2006.  Subjects were eligible for the study if 
they resided in one of 33 counties in central and eastern North Carolina, were African 
American or White, were 40-79 years of age, had a North Carolina driver’s license, had no 
previous diagnosis of colon or rectal cancer, and were able to give informed consent and 
complete the interview.  African Americans were over-sampled to increase their 
representation in the study. This study was approved by the institutional review board at the 
University of North Carolina-Chapel Hill. 
Cases had a primary diagnosis of rectal (including sigmoid and rectosigmoid 
junction) cancer during the study period. Cases were obtained from the rapid ascertainment 
system of the North Carolina Central Cancer Registry and diagnoses were confirmed our 
study pathologist.  Permission was received from the primary physician before contacting 
cases.  There were a total of 1,831 potentially eligible cases identified.  Fifty-seven (3%) of 
these were excluded for physician refusal and 357 (19%) were found to be ineligible.  Of the 
remaining 1,417 eligible cases, 118 (8%) could not be contacted and 242 (17%) refused; 
therefore, 1,057 (75%) had an in-person interview.  The overall response rate (number of 
persons interviewed divided by the total number of eligible persons) for cases was 74% (76% 
and 70% for White and African American cases, respectively). 
Controls under the age of 65 were identified using lists provided by the North 
Carolina Division of Motor Vehicles and the Center for Medicaid and Medicare Services for 
those 65 and older. Controls were selected using a randomized recruitment procedure based 
on sampling probabilities within blocks defined by 5-year age group, sex, and race (23).  
There were a total of 2,345 potentially eligible controls, but 518 (22%) were found to be 
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ineligible.  Of the 1,827 eligible controls identified, 325 (18%) could not be contacted, 483 
(26%) refused to be contacted; therefore, 1,019 (56%) were interviewed.  The overall 
response rate for controls was 56% (58% and 46% for White and African American controls, 
respectively). 
The analyses were restricted to those who completed all components of the study 
(n=1987).  We further excluded 83 participants with implausible values for total energy 
intake (<800 kcal/day and >5000 kcal/day for men and <600 kcal/day and >4000 kcal/day for 
women) (24).  Therefore, the analytic sample for this report included 1520 Whites (720 
cases, 800 controls) and 384 African Americans (225 cases, 159 controls). 
 
2. Data Collection  
 Trained nurse-interviewers collected all data in participants’ home or another 
convenient location using standard questionnaires.  We collected information on age at 
diagnosis, socioeconomic indicators, household information, physical activity, medical 
history, non-steroidal anti-inflammatory drug use, smoking history, and first degree family 
history of colorectal cancer.  Dietary information was obtained using the 124-item Diet 
History Questionnaire (DHQ), developed by the National Cancer Institute (NCI) (25, 26).  
Participants were asked to recall their intake in the 12 months prior to diagnosis (cases) or 
interview (controls).   There were 10 frequency options for each food, as well as 3 choices to 
estimate portion size.  Nutrient and total energy intakes were based on the nutrient content of 
each food item, frequency of consumption, and portion size, and were determined using 
software provided by the NCI. The DHQ also collected detailed information on the type, 
dose, and frequency of dietary supplement use.  The nutrients of interest for this study were 
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antioxidant nutrients (vitamin C, vitamin E, β-carotene, selenium) and DNA methylation-
related nutrients (folate, vitamin B12, vitamin B6) from food and supplements. 
  
3. Statistical Analyses 
 All analyses were done using SAS 9.1 software (SAS Institute, Inc., Cary, NC). We 
stratified the analyses by race and compared characteristics of cases and controls.  We used 
chi-square and Wilcoxon rank-sum tests to make these comparisons with regard to 
categorical and continuous variables, respectively.  Each nutrient was categorized into 
quartiles based on intake among race-specific controls.  Unconditional logistic regression 
models were used to determine odds ratios (OR) and 95% confidence intervals (95% CI) for 
the association between nutrient intake and risk of rectal cancer.  We examined these 
associations for nutrient intake from foods only, as well as total intake (food plus dietary 
supplements). Nutrients were examined in separate models.  We also simultaneously 
controlled for other micronutrients to examine the combined effect of nutrients in both 
categories (i.e. all antioxidant nutrients and all DNA methylation-related nutrients).  All 
logistic models included an offset term to adjust for the sampling probability. To assess 
confounding, the following covariates were tested in a bivariate model with each nutrient: 
age (continuous), sex, education (less than or equal to high school, some college, college 
graduate/advanced degree), smoking status (never, current, former), prior BMI (i.e., in the 
year prior to interview for controls and diagnosis for cases) (normal, overweight, obese), 
physical activity (quartiles of metabolic equivalent (MET)-minutes/day), first-degree family 
history of colorectal cancer (yes, no), non-steroidal anti-inflammatory drug use (yes, no), and 
total energy intake (continuous).   All models were adjusted for total energy intake to account 
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for differences in total energy between cases and controls and whites and African Americans. 
Covariates that produced at least a 10% change in any of the nutrient coefficients were 
considered potential confounders, and a backwards-stepwise procedure was done to obtain 
the final model.  Any variable that was a confounder in any model was retained in all models. 
A linear trend test was conducted using median quartile values among race-specific controls, 
which were incorporated into the logistic regression model as a continuous predictor and 
weighted by the inverse of the variance.  Interactions were tested by including a cross-
product term for the variables of interest in the model.  
 
D.  Results  
 Table 3 presents demographic and lifestyle characteristics of rectal cancer cases and 
respective controls stratified by race.  In both Whites and African Americans, cases were 
slightly younger, had a higher mean BMI one year ago, and greater total daily energy intakes 
than their respective controls.  Fewer White cases reported using non-steroidal anti-
inflammatory drugs compared to controls (35.1% vs. 45.7%, p<0.0001).  In African 
Americans, significantly more cases had a first-degree family history of CRC (p=0.03). In 
controls, a larger proportion of African Americans were obese and more whites were college 
graduates.   
Mean nutrient intakes for White and African American rectal cancer cases and 
controls are given in Table 4.  Nutrient intake was evaluated by the contribution from food 
sources only and from food and dietary supplements combined.  There were significant 
differences in intake between cases and controls in both racial groups. In general, White 
cases had lower mean nutrient intakes than controls, while African American cases had 
 47
higher nutrient intakes than their respective controls.  In both whites and African Americans, 
total (food plus supplements) mean intakes for most nutrients were significantly different 
between cases and controls (all p-values < 0.05).  More specifically, White controls had 
higher intakes of all nutrients, except selenium, compared to White cases; African American 
cases reported higher consumption of vitamin C, vitamin E, folate, vitamin B6, and vitamin 
B12 than their respective controls.  The contribution of supplements to total selenium intake 
was negligible in both racial groups.  In controls, African Americans reported significantly 
lower total mean intakes for most nutrients compared to whites, and the higher intakes in 
whites was mainly due to contributions from dietary supplements.  For example, daily 
vitamin E levels from food sources only in White and African American controls were 
similar (12.0 mg αTE and 11.1 mg αTE, respectively); however, total vitamin E intake was 
103 mg αTE  among Whites and 47 mg αTE  among African Americans.   
Tables 5 and 6 give the associations (OR and 95% CI) between rectal cancer and 
nutrients in our study population, stratified by race.  The ORs presented are based on race-
specific quartile cut-points, although ORs estimated using identical cut-points for both races 
were similar.  Table 3 presents results for antioxidant nutrients (vitamins C and E, β-
carotene, and selenium).  In whites, the highest quartiles of all nutrients were associated with 
a statistically significant lower risk of rectal cancer compared to the lowest quartile, except 
for total vitamin E intake. The greatest risk reduction was observed for total β-carotene 
intake (Q4 vs. Q1 OR: 0.47, 95%CI 0.33-0.66).  For vitamins C and E, the association with 
risk was stronger for food sources only than from total intake.  For example, the OR for high 
vitamin C intake from food only was 0.49 (95% CI 0.35-0.69) and 0.62 (95% CI 0.45-0.86) 
from food and supplements combined.  In African Americans, high selenium intake had a 
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strong inverse association with rectal cancer risk: total selenium intake was associated with a 
75% lower risk (OR: 0.25, 95% CI 0.08-0.84). The combined effect of all antioxidant 
nutrients on risk reduction in whites was less than the significant associations observed for 
single nutrients.  
  Table 6 gives results for DNA methylation-related nutrients (folate, vitamin B6, 
vitamin B12). There were significantly lower risks associated with all nutrient intakes in 
whites when contrasting the highest and lowest quartiles of intake, but only marginally 
significant for total folate intake (OR: 0.71, 95% CI 0.50-1.01).  High intake of vitamin B12 
from food in Whites had the strongest (58%) reduction in risk (OR: 0.42, 95% CI 0.28-0.63, 
p <0.0001).  The combined effect of all DNA methylation-related nutrients (Q4 vs. Q1 OR: 
0.62, 95%CI 0.44-0.88) was stronger than the independent associations for total folate and 
total vitamin B6.  In African Americans, total folate, vitamin B6, and vitamin B12, as well as 
the combined effect of all DNA methylation-related nutrients were suggestive of elevated 
risk, although odds ratios were not statistically significant.    
 Since whites had higher nutrient intakes and less total energy intakes compared to 
African Americans, the nutrient densities were also greater in whites.  When we examined 
the effect of energy adjustment, there were slightly stronger associations for energy-adjusted 
estimates compared to ORs not adjusted for total energy. For example, the energy-adjusted 
odds ratio for the highest category of vitamin C intake in whites was 0.62 (95% CI 0.45-
0.86); however, the non-energy-adjusted estimate was 0.69 (95% CI 0.50-0.94).  In African 
Americans, the energy-adjusted and non-energy-adjusted estimates for total vitamin C were 
1.45 and 1.91, respectively, although neither was statistically significant. 
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E.  Discussion 
In this large population-based case-control study, all antioxidant nutrients were associated 
with reduced rectal cancer risk in whites, and selenium reduced risk in African Americans.  
Inverse associations with DNA methylation-related nutrients were only observed in whites 
yet appeared to elevate risk in African Americans. To our knowledge, this is the first study to 
report associations between micronutrients and rectal cancer risk in African Americans.  
There were notable differences in mean nutrient intakes between whites and African 
Americans.  In general, African American controls reported lower mean intakes than White 
controls, primarily due to the greater contribution to intake from dietary supplements in 
whites.  The prevalence of any dietary supplement use in the last 12 months among our 
control population was 72% in Whites and 53% in African Americans.  It has been estimated 
that approximately 50-70% of non-institutionalized U.S. adults take dietary supplements in 
the form of multivitamin/mineral or single nutrient supplements (19, 27, 28), and Radimer, et 
al also noted that supplement use patterns differ by race (19).   Therefore, it is necessary to 
collect detailed information on supplement use when assessing the effect of micronutrients 
on disease risk, especially in diverse populations.  
Findings in this present study for whites are consistent with the hypotheses that 
dietary antioxidants may reduce the risk of rectal cancer.  In addition to their antioxidant 
properties, these nutrients may also inhibit tumor development by stimulating the immune 
system and (2) and regulating cell growth (29, 30).  Our results are in agreement with other 
observational studies reporting significant inverse associations for dietary antioxidant intake 
and colon cancer (4, 7, 31, 32) and colorectal cancer (4, 7).  Kune and colleagues reported 
rectal cancer risk reductions for high intakes of vitamin C, vitamin E, and selenium (7), and 
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elevated risk of rectal cancer has been observed for low vitamin E intakes in women (21).  
On the contrary, there was no effect of vitamin E on colon cancer in the Women’s Health 
Study clinical trial (33).  Most of the current evidence has been limited to non-African 
American populations; however, Satia et. al. noted significant inverse associations with colon 
cancer for high intakes of β-carotene, vitamin C, and vitamin E in African Americans (31). 
We also found intakes of DNA methylation-related nutrients to be associated with 
reduced risk of rectal cancer in whites.  Results are conflicting regarding the effect of folate 
on colorectal cancer development.  In a recent report of the Netherlands Cohort Study, the 
authors did not find folate to be significantly associated with colorectal cancer risk in men or 
women (34).  Null findings have also been reported for folate and colon cancer (5, 7, 31, 35, 
36).  The most recent report from the World Cancer Research Fund/American Institute for 
Cancer Research indicated that there is only limited suggestive evidence that folate reduces 
the risk of colorectal cancer (37).  Epidemiologic studies of vitamin B6 and B12 are limited 
in comparison to studies on folate intake.  The present study is in agreement with findings 
from an Australian case-control study in which there was a significant rectal cancer risk 
reduction for the highest category of vitamin B6 and B12 intake (7).  On the other hand, two 
large prospective studies observed an elevated risk of rectal cancer in women for high intake 
of vitamin B6 (5, 34).  These discrepant findings may be due to inherent biases in case-
control studies, the method of dietary assessment, or variation in intakes of these 
micronutrients. We did not observe effect modification by alcohol for any of these DNA 
methylation-related nutrients, although alcohol is a known to interact with these nutrients 
(38).  This may be because the average alcohol intake in our study population was low 
(<10g/day), thereby limiting our ability to detect any modifying effects by alcohol intake. 
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The reasons why the associations between micronutrients and rectal cancer differ for 
whites and African Americans are not totally clear.  Surprisingly, high total intakes of all 
nutrients except selenium appeared to elevate the risk of rectal cancer in African Americans, 
although odds ratios were not significant.  This direct association may be due to the source of 
these nutrients; however, after controlling for fruit and vegetable consumption there was still 
a non-significant positive association with risk.  To our knowledge, this is the first study to 
report such strong rectal cancer risk reduction in African Americans for high intake of 
selenium (75% risk reduction); however, this could be a chance finding.  Also, due to our 
small sample of African Americans, we may have missed other statistically significant 
associations, and these small sample size may also have led to unstable estimates  Results 
from other epidemiologic studies with adequate African American representation are needed 
to confirm (or dispute) these findings.   
It is interesting to note that for all DNA methylation-related nutrients in whites, the 
risk reduction was greater for intake from food sources only compared to total intake (food 
plus supplements). This phenomenon was also seen for vitamins C and E intakes.  In African 
Americans, the suggested risk elevation was actually greater for total intake than from food 
alone.  Other studies have reported null effects of supplement use on colorectal cancer (8, 39) 
and adenomas (9, 40).  For example, compared to the placebo, 1mg/day of folic acid did not 
reduce the risk of colorectal adenomas, the precursor to colon and rectal cancer, and actually 
increased the risk of advanced adenomas in the Aspirin/Folate Polyp Prevention Study (9). 
There are several possible explanations for these findings. This may be due to the dual effect 
of folate, depending on dosage and time of exposure.  While adequate folate intake may 
suppress tumor development, excessive intake may not offer additional benefit or even 
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enhance carcinogenesis, especially when there are pre-existing lesions (41). These disparate 
findings may also reflect the different chemical structures and biological pathways of natural 
folate and synthetic folic acid.  Folic acid is more bioavailable and therefore more readily 
absorbed than natural folate found in food (42).  However, high circulating levels of 
unmetabolized folic acid may reduce the immune response against carcinogenic cells by 
reducing the amount of natural killer cells (42). Clinical trials have also found no evidence 
for associations of vitamin C, vitamin E, or β-carotene with reduced risk of CRC (8, 39). One 
trial reported a significant inverse association of vitamin E supplementation and colon cancer 
risk, but there was no statistically significant association with rectal cancer (8). Therefore, 
these supplements may have different effects on colon and rectal cancer.  Also, vitamins C 
and E may exert pro-oxidant effects, promoting oxidative DNA damage, at high 
concentrations. Our study results suggest that nutrient intake from dietary supplements may 
not help reduce rectal cancer risk, and that intake from food sources alone may be more 
relevant for risk reduction.  This could be because supplement use only benefits those with 
suboptimal nutrient intakes, while providing no benefit for those with adequate intakes.  In 
our study, the mean intake of these micronutrients from food alone was above the daily 
recommended intakes for both whites and African Americans (43).  In addition, other 
compounds of natural foods such as phytochemicals and fiber may be chemopreventive and 
act in synergy with these nutrients to reduce rectal cancer risk, and it is likely that past and 
long-term supplement use may be associated with rectal cancer risk as opposed to recent use.  
Currently, the overall evidence for recommending supplements for rectal cancer is weak (44, 
45). 
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A major strength of this study was our large sample size, especially the number of 
rectal cancer cases.  This allowed us to observe associations that would be undetectable in 
studies with fewer participants.  Our study is among the first reports of micronutrient intake 
and rectal cancer risk in African Americans.  We collected detailed information on dietary 
supplement use to include in our assessment of total nutrient intake.   
There are some limitations worth noting.  Our study was subject to potential biases in 
case-control studies such as recall bias.  It is possible that there was differential recall 
between cases and controls.  Differential response rates between cases and controls, as well 
as between whites and African Americans, could have biased our results.  There was also the 
potential of measurement error; however the diet history questionnaire has been validated, 
although not in African American populations (25).  Due to our small sample size of African 
Americans, some significant associations may have been missed because of low statistical 
power.   
In summary, the present findings add to the evidence that dietary antioxidants 
(vitamin C, vitamin E, β-carotene, selenium) and DNA methylation-related nutrients (folate, 
vitamin B6, vitamin B12) are associated with lower risk of rectal cancer in whites.  Our 
results also support the hypotheses of mechanisms by which these nutrients may play a role 
in preventing colorectal cancer.  This study provides evidence that selenium may reduce risk 
in African Americans.  We observed striking differences in the relationship between the 
micronutrients and rectal cancer in whites and African Americans.  This stresses the 
importance of examining these associations by race in large racially diverse samples.  
Furthermore, intakes from dietary supplements appeared to reduce the risk reduction for 
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some nutrients, suggesting that optimal intakes of these nutrients from food sources alone 
may be sufficient to lower risk of rectal cancer. 
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F. Tables 
 
Table 3 Characteristics (means and standard deviations, percents) of cases and controls in the North Carolina 
Colon Cancer Study-Phase II (2001-2006), by race 
 
            Whites (N=1520) 
 
 Cases (n=720)    Controls (n=800)         
      African Americans (N=384) 
  
 Cases (n=225)    Controls (n=159)        
Sex (%)  
     Male 
     
                                        
58.3                   60.5 
 
                                        
52.4                     52.2 
 
Age (years) (%)  
     40-49 
     50-59 
     60-69 
     70-79 
  Mean(SD) 
                                    
19.2                   12.1 
27.5                   26.6 
31.5                   34.4 
21.8                   27.0 
59.6(10.3)         61.7(9.8)                      
                                          
21.3                     17.5 
29.2                     22.7 
33.8                     41.6 
15.7                     18.2 
58.0(10.0)            60.3(9.8)     
   
Education (%)  
    <=High School 
    Some College 
    College graduate/Advanced degree 
                                   
50.3                   39.0 
25.1                   25.9 
24.6                   35.1 
                                          
61.8                      58.5 
22.2                      25.8 
16.0                      15.7 
 
Body Mass Index (1yr ago) (%)  
     Normal (18.5-24.9 kg/m2) 
     Overweight (25.0-29.9 kg/m2) 
     Obese (≥30.0 kg/m2) 
   Mean(SD) 
 
Physical activity (MET-min/day a) (%) 
     Quartile 1 
     Quartile 2 
     Quartile 3 
     Quartile 4 
Mean(SD) 
 
Total energy intake (kcal/day)  
Mean(SD)  
 
                                      
22.7                    30.3 
38.8                    40.7 
38.5                    29.0 
29.2(6.3)         28.0(5.5)     
 
 
25.4                    24.5 
24.4                    23.5 
21.1                    26.5 
29.1                    25.3 
2250.0(661.8)    2152.7(473.4) 
 
 
2245.9(826.2)     2143.0(790.9)        
                                          
17.4                      18.1 
31.6                      36.2 
50.9                      45.6 
31.6(7.7)              29.9(6.5)    
 
 
30.7                    28.9 
25.5                    28.9 
16.0                    19.5 
27.8                    22.8 
 2178.4(545.5)   2152.8(494.2) 
 
 
2423.6(953.3)    2207.7(891.6) 
 
Smoking Status (%)  
     Current Smoker 
     Former Smoker 
     Never Smoker 
    
                                           
15.6                    13.5 
47.3                    48.7 
37.1                    37.8 
 
                                           
22.7                      17.0 
38.2                      42.1 
39.1                      40.9 
 
NSAID use b(%)  
     Yes 
      
                                   
35.1                    45.7 
 
                                          
24.4                      22.8 
 
First degree family history of CRC (%)  
    Yes 
     
                                           
13.2                    11.3 
             
 
11.8                       5.2 
               
a metabolic equivalent minutes per day 
b greater than or equal to 15 non-steroidal anti-inflammatory drugs (NSAID) per month in the past 5 years 
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 V.  Associations of red meat, fat, and protein intake with rectal cancer risk 
A. Abstract 
Studies suggest that red and processed meat consumption elevate the risk of colorectal 
cancer; however, the relationship between red meat, as well as fat and protein, and rectal 
cancer specifically is not clear.  We determined the risk of rectal cancer associated with red 
and processed meat, fat, and protein intakes in whites and African Americans.  There were 
945 cases of rectal cancer (including sigmoid and rectosigmoid) cases and 959 controls.  We 
assessed dietary intake in the 12 months prior to diagnosis for cases and interview for 
controls.  Multivariate logistic regression analyses were used to obtain odds ratios (OR) and 
95% confidence intervals (95% CI).  There was no association between total fat, saturated 
fat, or monounsaturated fat and rectal cancer risk.  In African Americans, the OR of rectal 
cancer for polyunsaturated fat was 0.28 (95% CI 0.08-0.96).  The percent of energy from 
protein was associated with a 47% risk reduction in whites (OR: 0.53, 95% CI 0.37-0.77). 
Total red meat intake was not related to rectal cancer in either race group, but beef/pork/lamb 
consumption in whites was associated with a marginally significant risk reduction (OR: 0.66, 
95% CI 0.43-1.00).  Our results do not support the hypotheses that fat, protein, and red meat 
increase the risk of rectal cancer. These findings demonstrate the potential value of 
examining these associations by race. 
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B. Introduction 
 Colorectal cancer (CRC) is the fourth most common cancer in the U.S. and accounts 
for approximately 9% of all cancer deaths (1).  Diet is widely believed to be associated with 
CRC development, and is a modifiable risk factor. Therefore, there is great interest in better 
understanding which dietary factors may be associated with higher or lower CRC risk. In 
particular, increased consumption of dietary fat, protein (mainly animal fat and protein), and 
have shown strong correlations with CRC cancer incidence in ecological studies (2-5). 
Observational studies in the U.S. have generally reported that high intakes of red meat and 
processed meat may increase risk for CRC (6, 7). A comprehensive review by the World 
Cancer Research Fund/American Institute for Cancer Research concluded that there was 
convincing evidence that red meat and processed meat increases CRC risk, but that the 
evidence regarding the role of foods containing animal fat is limited (8). Several hypotheses 
have been proposed to explain a possible relationship between red meat and CRC risk.  These 
hypotheses relate to two primary nutrients in red meat, i.e. fat (9-11) and protein (3, 12), as 
well as components of processed red meat such as N-nitroso compounds (9, 13), and factors 
produced while cooking red meat at high temperatures, namely heterocyclic amines and 
polycyclic aromatic hydrocarbons (5, (3, 9, 13).   
 Colorectal cancer consists of carcinomas of the colon and rectum, and rectal cancer 
comprises approximately one-third of all colorectal cancers. It has been suggested that there 
are different etiologies for colon and rectal cancer (14, 15); therefore, it is important to 
examine risk factors separately for both sites.  Some investigators have studied associations 
between meat intake and sub-sites of the colorectum (16-18); however, the currently 
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available evidence regarding the associations of red meat, fat, and protein with rectal cancer 
risk is inconclusive.    
 In this study, we examined associations of red meat, fat, and protein intake with risk 
for rectal cancer in African Americans and whites in a large case-control study in North 
Carolina (NC).  This study adds to the literature in two ways: it contributes to the body of 
knowledge regarding diet and rectal cancer risk and is, to our knowledge, the first study to 
examine these associations in African Americans.  
 
C. Methods 
1. Study design and population 
 The North Carolina Colon Cancer Study-Phase II is a population-based study 
conducted between May 2001 and September 2006.  Cases and controls were selected 
through a randomized recruitment approach that used age-, sex-, and race-specific incidence 
rates to calculate selection probabilities (19, 20).  African Americans were over-sampled to 
increase their representation in the study.  The eligibility criteria for all subjects were: age 
40-79, resident in one of 33 target counties in central and eastern NC,  a NC driver’s license,  
no history of colon or rectal cancer, able to give informed consent, and able to complete the 
interview.   
 Rectal (including sigmoid and rectosigmoid) cancer cases were selected through the 
rapid ascertainment system (21) of the NC Central Cancer Registry.  Cases were diagnosed 
with a primary adenocarcinoma between May 2001 and September 2006.  Our study 
pathologist confirmed these diagnoses using pathology slides and medical records.  Controls 
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were randomly selected from the NC Department of Motor Vehicles if under age 65 and the 
Centers for Medicare and Medicaid Services if 65 and older. 
 A total of 1057 out of 1417 eligible cases and 1019 out of 1827 eligible controls had 
an interview.  Among those eligible to participate, the overall response rate (number 
interviewed/number eligible) for cases was 74% (76% for Whites, 70% African Americans) 
and 56% in controls (58% for Whites, 46% for African Americans).  For this analysis, we 
further excluded 89 participants who did not complete all components of the study, and an 
additional 86 participants who had implausible energy intake values (<800 kcal/d and >5000 
kcal/d for men and <600 kcal/d and > 4000 kcal/d for women (22).  The final analytic sample 
included 945 cases (720 White, 225 African American) and 959 controls (800 White, 159 
African American). This study was approved by the Institutional Review Board at the 
University of North Carolina-Chapel Hill. 
 
2. Data collection  
 The National Cancer Institute’s (NCI) Diet History Questionnaire (DHQ) was used to 
assess dietary intake.  The DHQ is a 124-item food frequency questionnaire that includes 
questions on dietary supplement use and fat added to foods (23, 24).  The questionnaire was 
administered by trained nurse-interviewers, who asked subjects to recall their usual dietary 
intake over the 1 year prior to diagnosis for cases or interview for controls.  Nutrient intakes 
were determined using software provided by the NCI, and were based on the nutrient content 
of each food item, the frequency of consumption, and portion size.  The nutrients of interest 
for this study were total fat, saturated fat, monounsaturated fat (MUFA), polyunsaturated fat 
(PUFA), protein, and red meat.  The two categories of red meat were beef/pork/lamb 
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(including veal, lamb, beef steaks, beef roast, beef mixtures, burgers, ham (not luncheon 
meat), pork, bacon, ribs) and processed meat (including sausage, hot dogs, and all cold-cuts).  
Interviewers administered a separate questionnaire to collect data on covariates including 
demographic and household information, medical history, medication use, physical activity, 
smoking status, and family history of colorectal cancer.    
 
3. Statistical analysis 
 Analyses were conducted using SAS (version 9.1; SAS Institute, Inc., Cary, NC) and 
based on 2-sided p-values.  Participants were stratified by race and case-control status.  The 
Wilcoxon non-parametric rank sum test was used to assess differences in mean nutrient 
intakes between White and African American controls.  We calculated adjusted odds ratios 
(OR) and 95% confidence intervals (95% CI) using unconditional logistic regression models.  
PROC LOGISTIC in SAS was used with an option in the MODEL statement to include 
offsets.  The offset term takes into account the selection probabilities based on age, race, and 
sex, which were used to identify eligible participants (20).  Quartiles were constructed for 
nutrient and red meat intakes based on the distribution among race-specific controls for 
stratified analyses.  This was done to account for possible differences in the variation in 
range of intake for whites and African Americans.  The following covariates were considered 
for inclusion in the multivariate models: age (continuous), sex, education (≤ high school, 
some college, college graduate/advanced degree), smoking status (never, current, former), 
prior body mass index (i.e. BMI in the 1 year prior to interview for controls and diagnosis for 
cases)(normal, overweight, obese), physical activity (continuous), first degree family history 
of CRC (yes, no), non-steroidal anti-inflammatory drug (NSAID) use (yes, no), calcium 
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(continuous), folate (continuous), fiber (continuous), and total energy intake (continuous).  
Multivariate models were created using backward elimination and included covariates that 
changed the odds ratios of interest by ≥ 10%.  All covariates met the criteria for inclusion, 
except smoking status and folate.  P-values for trend were obtained using the median intake 
values in controls of each quartile as a continuous variable in the model, which was weighted 
by the inverse of the variance.  For each red meat category, we constructed 3 multivariate 
models: model 1 included age, sex, education, prior BMI, family history, NSAID use, 
physical activity, calcium, fiber, and total energy; model 2 consisted of the covariates in 
model 1 and energy-adjusted saturated fat; model 3 consisted of the covariates in model 1 
and energy-adjusted protein.  We examined these 3 different models to determine the extent 
to which the association between red meat and rectal cancer can be attributed to overall 
saturated fat or protein intake since it has been suggested that these nutrients in red meat 
contribute to the elevated risk of rectal cancer.  Therefore, these 3 different model 
specifications test the hypothesis that fat and protein intake mediate the association between 
red meat and rectal cancer. 
 
D. Results 
Table 7 summarizes characteristics of cases and controls by race with respect to 
potential confounders and dietary intake.  Cases in both race groups were younger, had less 
education, and a higher mean BMI than their respective controls.  Among whites, regular use 
of non-steroidal anti-inflammatory drugs was much more frequent in controls compared to 
cases, and a greater proportion of African American cases had a family history of CRC than 
African American controls.  Some nutrient intakes and meat consumption patterns varied by 
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race; among controls, on average, whites had significantly greater calcium, fiber, and alcohol 
intakes than African Americans.  There were no appreciable differences by race in total 
energy, dietary folate, and fat. The percent of energy from protein was greater for whites, 
although absolute intakes did not differ significantly by race.  Whites reported a slightly 
higher mean intake of beef/pork/lamb than African Americans (52.1 versus 50.1 g/d, 
respectively (p=0.05)), while African Americans had greater processed meat consumption 
than whites (24.5 versus 18.7 g/d, respectively (p=0.006)). 
 As shown in Table 8, absolute intakes of total fat and the percent of energy from total 
fat had null associations with risk in whites and non-statistically significant inverse 
associations in African Americans.  The ORs for saturated fat and the percent of energy from 
saturated fat were not statistically significant in either race group; however, we observed a 
significant inverse trend in African Americans for the percent of energy from saturated fat (p-
value for trend = 0.004).  With regards to the unsaturated fats (MUFA and PUFA), there 
were no associations with risk in whites.  In African Americans, the highest category of 
PUFA intake was associated with a considerable reduced risk (OR: 0.28, 95% CI 0.08-0.96).  
The ORs for protein intake were less than one in both race groups, although there was no 
association in African Americans.  In whites, high absolute protein intake was suggestive of 
lower rectal cancer risk (OR: 0.57, 95% CI 0.32-1.01).  Also in whites, high percent of 
energy from protein yielded a significant risk reduction (OR: 0.53, 95% CI 0.37-0.77), and 
the odds ratios decreased progressively with increasing percent of energy from protein (p-
value for trend=0.003). 
 Table 9 shows the relationship between rectal cancer risk and total red meat, 
beef/pork/lamb, and processed meat.  For total red meat, we did not find any statistically 
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significant associations with risk in whites or African Americans in any of the models.  The 
Model 1 ORs for the highest category of beef/pork/lamb consumption were similar in both 
race groups, yet only approached statistical significance in whites (OR: 0.66, 95% CI 0.43-
1.00).  There was a slightly stronger risk reduction in whites when we controlled for energy 
from saturated fat (OR: 0.60, 95% CI 0.39-0.93).  Moderately high processed meat 
consumption had a significant positive association with risk in whites (Q3 vs. Q1 OR: 1.43, 
95% CI 1.02-2.02), which was even stronger when we adjusted for energy from protein (Q3 
vs. Q1 OR: 1.56, 95% CI 1.10-2.20).  There were no statistically significant associations in 
African Americans, although odds ratios suggest lower risk for all red meat. 
  
E. Discussion 
 In this large case-control study of 945 rectal (including sigmoid and rectosigmoid) 
cancer cases and 959 controls, we did not find any evidence of associations between total and 
saturated fat and rectal cancer risk, although monounsaturated fatty acids appeared to reduce 
risk in African Americans.  Our study does not support the hypothesis that high red meat or 
processed meat consumption increases the risk of rectal cancer.  Rather, we found that that 
protein intake and beef/pork/lamb consumption reduces the risk of rectal cancer in whites. 
 The results for total fat intake are in agreement with several previous case-control 
(25, 26) and cohort (27, 28) studies, which generally found no statistically significant 
association with rectal cancer risk.  Several investigations found the relationship between 
overall fat intake and rectal cancer to vary by gender.  For example, an early study by 
Freudenheim, et al. observed an approximately 2-fold higher rectal cancer risk in males (OR: 
1.96, 95% CI 1.19-3.24), but no clear association in females (29).  Similarly, a more recent 
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and larger case-control study in Canada found a positive association among male participants 
(OR: 1.7, 95% CI 1.1-2.6), but no association in females (30).  We did not find evidence of 
effect modification by gender in our analyses of total fat and rectal cancer. 
 When examining the association between dietary fat and rectal cancer, it is important 
to consider different types of fatty acids because they can have different and opposite effects 
on risk.  Experimental studies have shown that high saturated fat and omega-6 PUFAs 
increase the incidence of chemically induced colon cancer in animal models (31), while 
omega-3 PUFAs inhibit colorectal carcinogenesis in rodents (32, 33).  It has been suggested 
that the fat content, particularly saturated fat, in red meat may influence CRC risk by 
increasing the production of secondary bile acids that can promote colon carcinogenesis (11, 
34).  Postulated mechanisms regarding the protective role for omega-3 PUFAs include their 
ability to inhibit tumor growth and modulate the expression of pro-inflammatory genes (35, 
36).  There is limited evidence that foods containing animal fat increase the risk of CRC (8).  
For example, a combined analysis of 13 case-control studies found no evidence of an 
association between CRC and saturated fat, PUFAs, or MUFAs (37).  This is also the case 
for rectal cancer specifically, as studies have observed no association between saturated fat 
and rectal cancer (25-28, 38) as we did in the present study.  High intake of PUFAs in our 
study was inversely related to risk, but only reached statistical significance in African 
Americans, suggesting a strong risk reduction (72%) in this race group.  However, it is 
possible that this was a chance finding.  Unfortunately, we were not able to distinguish 
between omega-3 and omega-6 PUFAs. 
 Total consumption of protein was significantly associated with reduced risk in whites 
and had a non-statistically significant association with lower risk in African Americans in the 
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present study.  There is limited epidemiologic evidence for a relationship between overall 
protein intake and rectal cancer risk.  A few studies reported no association between protein 
intake and rectal cancer risk (26, 28) while a case-control study in Italy reported a marginally 
significant risk reduction of rectal cancer for 100 calories/day from protein (39). These 
results are contrary to the hypothesis that increased protein intake may elevate rectal cancer 
risk due to components of protein degradation such as ammonia, phenolic compounds, 
amines, N-nitroso compounds, and possibly sulfides that are known to exert toxic effects in 
animal models and in vitro (12). 
 Meta-analyses of meat consumption and CRC risk have concluded that red meat and 
processed meat increase the risk of CRC, colon cancer, and rectal cancer (3, 9, 40), and that 
processed meat may be a stronger risk factor than fresh red meat (40, 41).  In contrast, 
findings from individual studies have not been consistent (16, 18, 25, 42-45); therefore, the 
biological mechanisms relating red meat intake to CRC risk remain speculative.  Individual 
studies investigating the relationship between red meat and rectal cancer specifically are also 
conflicting.  Some studies have reported a significantly higher risk of rectal cancer with 
increased red meat consumption (16, 43, 45) while others did not find any statistically 
significant associations (17, 18, 25, 28, 44, 46, 47).  Our study did not suggest that high total 
red meat intake elevates the risk of rectal cancer, although moderately high intakes of 
processed meat appear to be associated with significantly higher risk in Whites. Surprisingly, 
we found high beef/pork/lamb consumption to be associated with lower risk in whites. 
 It was initially hypothesized that the saturated fat and protein content of red meat 
increases rectal cancer risk for reasons previously mentioned.  This hypothesis has been 
explored in animal studies, and it was found that lean beef did not promote colon 
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carcinogenesis in rats (48). When we controlled for energy from saturated fat in our analyses 
the risk estimates for the associations between red meat and rectal cancer were not 
appreciably altered; however, in whites, there was a trend toward a slightly stronger risk 
reduction for high beef/pork/lamb consumption.  Therefore, there was no evidence to indicate 
that the association of red meat and rectal cancer was mediated by saturated fat intake.  
Protein metabolism is another mechanism to explain the relationship between rectal cancer 
risk and red meat intake. Meat is a major source of protein and products of protein 
metabolism such as ammonia and N-nitroso compounds are known to have toxic effects (12). 
High protein intakes in the present study appeared to reduce the risk of rectal cancer in 
whites, mainly as the percent of total energy.  Controlling for protein intake in the analyses of 
red meat and rectal cancer risk in whites resulted in elevated risk estimates for total red meat, 
removed the significant risk reduction for high beef/pork/lamb intake, and strengthened the 
positive association with processed meat consumption.  Therefore, the protein content in red 
meat appears to contribute to rectal cancer risk reduction in whites.  No statistically 
significant changes for were observed in African Americans, although there were generally 
less favorable risk estimates when adjusting for protein.  
 Recently, more attention has been given to the potentially carcinogenic effects of 
heterocyclic amines (HCA) and polycyclic aromatic hydrocarbons (PAH) in an effort to 
explain the association between red meat and increased rectal cancer risk.  HCAs are 
mutagenic compounds formed when cooking meat at high temperatures such as grilling, 
frying, or oven-broiling, while PAHs are produced when grilling or broiling over an open 
flame (46).  In general, studies have shown well-done red meat and high mutagen indices to 
have strong positive associations with CRC risk (49, 50).  However, the risk posed by these 
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compounds may depend on the extent to which they are activated by metabolic enzymes 
(13).   
 Our findings do not support the hypotheses that fat, protein, and red meat increase the 
risk of rectal cancer, although these dietary components have generally been associated with 
elevated colon cancer risk.  There are several possible explanations for these findings.  Our 
results may simply reflect differences in colon and rectal cancer development.  There is 
evidence that colon and rectal cancer may have distinct etiologies (15, 51) as well as 
differences with regards to the metabolism of bile acids (14), expression of metabolizing 
enzymes (14), bacterial composition and pH (52), and genetic profile (15, 16). Another 
explanation may be that red meat intake in our study population was relatively low, and 
therefore perhaps below the level necessary to elevate risk.  For example, Larsson et al. 
reported a 63% increase in rectal cancer risk associated with 120 g/d of red meat; the mean 
total red meat intake in our study was 76 g/d.  These results may also reflect our inability to 
determine the amount of red meat consumed according to doneness and cooking methods, 
and thereby estimate the amount of HCAs and PAHs in the red meat.  These mutagenic 
compounds may be the culpable substances moreso than overall red meat consumption.   
 The reasons why some of our results differed by race are not totally clear.  No other 
available literature has reported the associations between diet and rectal cancer in African 
Americans. An early study of diet and colon cancer in African Americans did not observe 
any statistically significant associations between colon cancer and beef and pork 
consumption (53).  A population-based case-control study of colon cancer did not report any 
associations between colon cancer risk in African Americans and energy-adjusted saturated 
fat, protein, or red meat intakes (54, 55).  This study did find a significant colon cancer risk 
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reduction for high total fat intake in African Americans.  We realize that the relatively small 
sample of African Americans in our study may have resulted in reduced power to detect real 
associations and resulted in unstable estimates.  The risk differences remained after we 
estimated odds ratios using the same quartile cut-points in whites and African Americans; 
therefore, variation in the range of nutrient intake is also not a likely explanation for the 
racial differences in risk.   
 The population-based design and large sample size are among the strengths of this 
study.  It is noteworthy that this is among the first published reports of associations between 
fat, protein, red meat and rectal cancer risk in African Americans.  All data were collected in-
person using standard questionnaires administered by our nurse-interviewers, thereby 
minimizing the potential for misclassification.  Recall and response bias could have been 
introduced in our study and affected our results.  We also cannot exclude the possibility of 
measurement error due to the use of the food frequency questionnaire. 
 In summary, this study did not provide evidence that total or saturated fat is related to 
rectal cancer risk in whites and African Americans.  High intake of polyunsaturated fatty 
acids may reduce rectal cancer risk in African Americans, while protein intake may lower 
risk in whites.  There was no association between total red meat intake and rectal cancer, 
although beef/pork/lamb appeared reduce risk and processed meat may elevate risk in whites.  
These findings highlight the importance of examining these associations in large racially 
diverse populations and add to the knowledge base for dietary risk factors for rectal cancer.  
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 VI. Dietary patterns, food groups, and rectal cancer risk in Whites and African Americans 
 
A. Abstract 
 
Background: Associations between individual foods and nutrients and colorectal cancer have 
been inconsistent, and few studies have examined associations between food, nutrients, 
dietary patterns, and rectal cancer.  We examined the relationship between food groups and 
dietary patterns and risk of rectal cancer in non-Hispanic Whites and African Americans.  
Methods: Data were from the North Carolina Colon Cancer Study-Phase II and included 
1520 Whites (720 cases, 800 controls) and 384 African Americans (225 cases, 159 controls). 
Diet was assessed using the Diet History Questionnaire.  Multivariate logistic regression 
models were used to estimate odds ratios (OR) and 95% confidence intervals (95% CI).  
Results: Among Whites, non-whole grains and white potatoes were associated with elevated 
risk of rectal cancer, while fruit, vegetables, dairy, fish, and poultry were associated with 
reduced risk.  In African Americans, high consumption of citrus fruit and added sugar 
suggested elevated risk.  We identified three major dietary patterns in Whites and African 
Americans. The High Fat/Meat/Potatoes pattern was observed in both race groups, but was 
only positively associated with risk in Whites (OR: 1.84, 95% CI 1.03-3.15).  The 
Vegetable/Fish/Poultry and Fruit/Whole-Grain/Dairy patterns in Whites had significant 
inverse associations with risk. In African Americans, there was a positive dose-response for 
the Fruit/Vegetables pattern (Ptrend <0.0001), and an inverse linear trend for the 
Legumes/Dairy pattern (Ptrend <0.0001).  Conclusion: Our findings indicate that associations 
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of certain food groups and overall dietary patterns with rectal cancer risk differ between 
Whites and African Americans, highlighting the importance of examining diet and cancer 
relationships in racially diverse populations. 
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B. Introduction 
 Colorectal cancer (CRC) is the fourth most common cancer in the United States 
(U.S.) among men and women (1).  Incidence and mortality rates are highest among African 
Americans compared to other U.S. race/ethnic groups.  While some of this disparity can be 
attributed to access to care and socioeconomic differences (2), other reasons remain largely 
unknown.  It is generally accepted that diet plays an etiologic role in colorectal cancer 
development; however, studies examining associations of specific foods and nutrients with 
CRC risk have been inconsistent.  Moreover, most studies have focused on colon cancer only 
or the combination of colon and rectal cancer, while less attention has been given to the risk 
of rectal cancer specifically. 
 The majority of diet and cancer studies examine associations of individual nutrients 
with disease risk. Examining individual nutrients in relationship to cancer risk is beneficial 
for gaining insight into possible mechanisms of dietary components. This individual nutrient 
approach, however, is not adequate for considering the synergistic effect of highly correlated 
nutrients and other compounds found in foods (3).  Other studies have focused on food 
groups, which take into account the way the foods are typically consumed. Nonetheless, it 
has been suggested that dietary patterns represent a more logical approach, as the analysis of 
dietary patterns takes into consideration the synergistic effect of both foods and nutrients, 
neither of which is consumed in isolation.  Dietary patterns include numerous dietary 
exposures and are often associated with other health behaviors, such as physical activity, 
smoking, and cancer screening (4).  A common approach to identifying dietary patterns is 
factor analysis, which reduces a large number of variables into a small number of factors 
based on their degree of correlation (5).  These factors then represent dietary patterns in the 
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study population and are used as predictors in subsequent analyses of risk. Comparisons 
between the food/nutrient and dietary pattern approaches among previous studies have been 
difficult due to differences in study design, study populations, and statistical methods.  
 As noted above, few studies have examined associations of diet with rectal cancer 
risk separately, as most have combined rectal and colon cancers. However, true mechanisms 
underlying the etiology of colon and rectal tumors may be different (6, 7).   The objective of 
this work is to examine associations of food groups and dietary patterns (based on factor 
analysis) with risk of rectal cancer in a population-based case-control study of non-Hispanic 
Whites (Whites) and African Americans in North Carolina. To our knowledge, this is the first 
population-based study to examine these relationships in a racially diverse U.S. population. 
 
C.  Methods 
1. Study design and population 
 The North Carolina Colon Cancer Study-Phase II is a population-based case control 
study in a 33-county area in central North Carolina.  These counties include rural, suburban, 
and urban areas and are socioeconomically diverse.  Participants were selected using a 
randomized recruitment strategy that over-sampled African Americans and involved 
matching on 5-year age, sex, and race. This study was approved by the University of North 
Carolina’s Institutional Review Board. 
Cases 
 Rectal cancer cases were identified by the North Carolina Central Cancer Registry 
rapid ascertainment system and included those with cancers of the rectum, sigmoid, and 
rectosigmoid junction (ICD 154). Eligibility criteria for cases included:  age 40-79 at time of 
 92
diagnosis, diagnosed with a primary adenocarcinoma between May 2001 and September 
2006, have a North Carolina driver’s license or identification (because controls under 65 
were selected from Department of Motor Vehicle rosters), and able to give informed consent 
and complete the interview.  All diagnoses were confirmed by the study pathologist through 
review of pathology slides and reports. Cases with a non-invasive carcinoma or a previous 
diagnosis of colorectal cancer were excluded.  After notification of the primary physician, 
eligible cases were sent a letter describing the study and a race-matched enrollment specialist 
contacted them to explain the study and obtain their consent to participate.  Interviews were 
scheduled for consenting cases.  There were a total of 1831 cases sampled, 1417 of whom 
were eligible to participate.  Of the eligible cases, 118 (8%) were unable to be contacted, 242 
(17%) refused, and 1057 (75%) were interviewed.  The response rate, (number of persons 
interviewed divided by the total number of eligible persons), was 76% and 70% for Whites 
and African Americans, respectively. 
Controls 
 Using lists provided by the agencies, controls were randomly identified from the 
North Carolina Department of Motor Vehicles (NC DMV) (for those less than age 65) and 
from the Center for Medicaid and Medicare Services (CMS, formerly known as the Health 
Care Financing Administration), for those age 65 and older. Eligible controls were 40-79 
years old at the time of selection, resided in the 33-county study area, and had no previous 
diagnosis of colorectal cancer. Similar to cases, potential controls were sent an introductory 
letter and contacted by a race-matched enrollment specialist and in-person interviews were 
scheduled for controls who agreed to participate. Among eligible controls (1,827 out of 2,345 
sampled), 325 (18%) could not be contacted, 483 (26%) refused, and 1019 (56%) were 
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interviewed.  The response rates were 58% and 46% for White and African American 
controls, respectively. 
 
2. Data collection 
 All data were collected by trained nurse-interviewers in participants’ home or other 
convenient location.  
 Usual dietary intake was assessed using the Diet History Questionnaire (DHQ) 
developed and tested for validity by the National Cancer Institute (8-10). This instrument was 
validated in study samples that were racially diverse, with African Americans representing 
10-14% of these study samples (9, 10).  The DHQ consists of 124 separate food items and 
assesses the frequency of consumption and portion size consumed for each food item. 
Participants were asked to estimate their food and beverage intake in the past 12 months. The 
12-month period was chosen to take into account seasonal variation in food consumption.  
Cases were asked to estimate their usual frequency and portion size over the 12 month period 
prior to diagnosis, and controls were asked to estimate consumption during the 1 year prior to 
interview.  Daily intakes of nutrients and total energy were calculated with software provided 
by the NCI and developed for the survey instrument.  Nutrient intakes were determined using 
the frequency of consumption, reported portion size, and nutrient content. For the food group 
analysis, we examined the following U.S. Department of Agriculture (USDA) pyramid food 
groups (11) :  total grains, whole grains, non-whole grains (e.g. white bread, pasta, cereal), 
total vegetables, dark green vegetables, deep yellow vegetables, dry beans and peas, white 
potatoes, starchy vegetables, tomatoes, other vegetables(e.g. cabbage, cauliflower, Brussels 
sprouts, onions), total fruits, citrus fruits(including melons and berries), other fruits, total  
 94
dairy, milk, yogurt, cheese, total meat, beef/pork/lamb (i.e. red meat), processed meats, organ 
meats, fish and other seafood, poultry, eggs(i.e. eggs, egg whites, egg substitutes), soy 
products, nuts (e.g. peanuts, walnuts, seeds), added sugar (sugars added during processing, 
cooking, or at the table), and discretionary fat (i.e. excess fat in foods and fat added to foods).  
Average weekly intakes were calculated for each food group. There was a large proportion of 
non-consumers for the yogurt, organ meat, and soy food groups (58%, 49%, 76%, 
respectively). For this reason, we dichotomized (consumers vs. non-consumers) these foods 
in the food group analysis, and combined the yogurt group with the milk food group and 
excluded the organ meat and soy food groups in the factor analysis. 
 The participant questionnaire queried age at diagnosis, sex, race, education, annual 
income, use of non-steroidal anti-inflammatory drugs, smoking history, and first degree 
family history of colorectal cancer.    
 The analyses were restricted to participants who completed all components of the 
study (n=1987).  Participants with unreliable reported energy intakes (<800 kcal/day and 
>5000 kcal/day for men and <600 kcal/day and >4000 kcal/day for women) were also 
excluded (n=83 (50 men, 33 women)) because they were considered implausible based on 
daily energy requirements (12).  Thus, the analytic sample for this report included 1520 
Whites (720 cases, 800 controls) and 384 African Americans (225 cases, 159 controls).   
 
3. Statistical analyses 
 Descriptive statistics (means, standard deviations, and frequencies) were computed 
for all study variables by case-control status and race to describe the demographic and dietary 
characteristics of the study population.  Results were stratified by race because tests for 
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interaction indicated the presence of effect modification by race for some of the demographic 
and dietary variables.  Each food group was categorized into quartiles based on the 
distribution among race-specific controls. Odds ratios (OR) and 95% confidence intervals 
(95% CI) were calculated using unconditional logistic regression models to determine the 
association between the food groups and rectal cancer risk. These food group models 
included an offset term to account for the randomized recruitment and to allow us to obtain 
unbiased odds ratios, as well as the following covariates: age (continuous), sex, 
socioeconomic status (represented by education (less than or equal to high school, some 
college, college graduate/advanced degree) and  income (categorized)), BMI 1 year ago (i.e., 
in the year prior to interview for controls and diagnosis for cases) (normal, overweight, 
obese), physical activity (continuous), family history (yes, no), non-steroidal anti-
inflammatory drug use (yes, no), and total energy intake (continuous).   
 Dietary patterns were identified separately among White and African American 
controls using 21 predefined food groups in a principal components factor analysis.  This 
analysis was conducted using the PROC FACTOR procedure in SAS.  To determine the 
number of factors to retain, we considered eigenvalues >1, the scree plot, and the 
interpretability of the factors.  Extraction of these factors was followed by orthogonal 
rotation (the varimax rotation option in SAS) to obtain uncorrelated factors and enhance 
interpretability.  For each dietary pattern (factor), a factor score was calculated for cases and 
controls by summing intakes of the food items weighted by their factor loadings.   Pearson 
and Spearman correlation coefficients were used to examine the correlation of factor scores 
for each dietary pattern with other participant characteristics and dietary variables. Partial 
Pearson correlation coefficients adjusted for energy were obtained for the dietary variables.  
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Factor scores were categorized into quartiles based on the distribution in the control 
population for African Americans and Whites separately.  To determine the relationship 
between these dietary patterns and rectal cancer, we used unconditional logistic regression 
models to obtain odds ratios and 95% confidence intervals.  Test for trend was conducted by 
incorporating a variable for the median values of factor scores among race-specific controls 
observed for each food group quartile into a logistic regression model. The trend test was 
weighted by the inverse of the variance for the quartiles. All logistic regression models were 
adjusted for the same covariates as in the food group models. 
 All analyses were performed using SAS 9.1 software (SAS Institute, Inc., Cary, NC).  
Statistical tests were two-sided and p<0.05 was considered statistically significant.   
 
D. Results 
 The distribution of cases and controls by race is shown in Table 10.   Among Whites, 
controls were older and more educated, had a slightly lower mean BMI 1 year ago, and used 
more non-steroidal anti-inflammatory drugs than cases. Among African Americans, the mean 
age was less for cases than controls, while cases had a higher mean BMI.  In addition, a 
larger proportion of African American cases had a family history of CRC compared to 
controls.  All of these participant characteristics were significantly associated with the risk of 
rectal cancer in multivariate models, except annual income, smoking status, and family 
history (data not shown). 
 Tables 11 and 12 give the covariate-adjusted race-specific odds ratios (OR) and 95% 
confidence intervals for each food group among Whites and African Americans, respectively. 
The odds ratios presented are not mutually adjusted for the other food groups, although 
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estimates were similar when we controlled for the other primary food groups.  For Whites, 
high intakes of non-whole grains and white potatoes were significantly positively associated 
with rectal cancer risk (Table 11).  Conversely, fruit, dark green vegetables, deep yellow 
vegetables, other starchy vegetables, other vegetables, dairy foods, fish, and poultry were 
significantly associated with reduced risk for rectal cancer. High consumption of dark green 
vegetables had the strongest inverse association (OR: 0.41, 95% CI 0.29-0.58).   The highest 
quartile of red meat intake had an OR less than 1, but was not statistically significant.  High 
intake of other fruit and added sugar were associated with elevated risk in African Americans 
(OR: 3.25 95% CI 1.52-6.96 for other fruit; OR: 2.65 95% CI 1.11-6.34 for added sugar) 
(Table 12).  There was a significant lower risk associated with the second quartile of intake 
of total vegetables, other vegetables, total meat, and discretionary fat in African Americans. 
 Three dietary patterns were identified separately among White and African American 
controls using principal components analysis.   These 3 patterns explained 39% of the 
variance in Whites and 43% of the variance in African Americans.  Table 13 presents the 
factor loadings for the food groups on each dietary pattern for each race group.  The first 
dietary pattern, High Fat/Meat/Potatoes, was similar for both Whites and African Americans 
and had strong positive loadings for discretionary fat, non-whole grains, white potatoes, red 
and processed meat, cheese, and added sugar.  The second and third factors were only 
slightly different for Whites and African Americans.  For Whites, the second dietary pattern 
was characterized by high loadings of most vegetables, as well as fish and poultry, and was 
therefore labeled the “Vegetable/Fish/Poultry” (abbreviated as Veg/Fish/Poultry) pattern.  
The third dietary factor in Whites was labeled “Fruit/Whole Grain/Dairy” because of its high 
positive loadings of fruit, whole grains, and milk/yogurt. In African Americans, fruits also 
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loaded heavily on the second factor in addition to vegetables.  This factor was labeled 
“Fruit/Vegetables”.   The third factor in African Americans had strong loadings of nuts, 
beans and peas, and milk/yogurt, and was labeled “Legumes/Dairy”.    
 Table 14 shows correlations of the three separate dietary patterns in Whites and 
African Americans with selected participant characteristics and dietary variables. Age was 
inversely correlated with the High Fat/Meat/Potatoes pattern for both race groups, whereas 
education and income were positively correlated with the Veg/Fish/Poultry pattern in Whites.  
The dietary variables presented are those related to energy intake (i.e. total energy, fat, 
carbohydrate, protein, alcohol).  Folate and fiber were included because of their high content 
in fruits and vegetables.  The High Fat/Meat/Potatoes pattern had the highest correlation with 
total energy in Whites (r=0.86) and African Americans (r=0.82), while inversely related to 
carbohydrates, alcohol, folate, and fiber.  The Veg/Fish/Poultry pattern in Whites had a 
strong positive correlation with protein, and the Fruit/Vegetable pattern in African Americans 
was highly correlated with folate and fiber. 
 Associations (odds ratios and their 95% CI) of the dietary patterns (according to 
quartiles of factor scores) with rectal cancer risk, stratified by race, are given in Table 15.  
Estimates based on race-specific quartile cut-points are shown, although similar associations 
were observed when quartile cut-points were matched across ethnic groups.  Among Whites, 
high factor scores for the High Fat/Meat/Potatoes pattern had odds ratios suggestive of 
elevated rectal cancer risk (OR: 1.84, 95% CI 1.08-3.15).  The second and third patterns in 
Whites were significantly associated with reduced risk of rectal cancer.  The ORs for the 
highest quartiles for the Veg/Fish/Poultry and Fruit/Whole-grain/Dairy patterns were 0.47 
(95% CI 0.33-0.67) and 0.65 (95% CI 0.45-0.93), respectively.  In African Americans, the 
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High Fat/Meat/Potatoes and Legumes/Dairy patterns were suggestive of reduced risk, while 
the Fruit/Vegetables pattern suggested elevated risk.  None of the quartile estimates reached 
statistical significance.  There was, however, evidence of a positive linear trend for the 
Fruit/Vegetables pattern and an inverse dose-response for the Legumes/Dairy patterns 
(p<0.0001 for both).  We did not observe any effect modification by gender for any of the 
food group totals or dietary patterns. 
 
E. Discussion 
 This population-based case-control study examined the relationship of food groups 
and dietary patterns with the risk of rectal cancer in Whites and African Americans.  High 
intakes of fruit, vegetables, and dairy were associated with reduced rectal cancer risk in 
Whites, while African Americans had an elevated risk associated with other fruit and added 
sugar.  We identified three major dietary patterns and investigated the relationship between 
these patterns and rectal cancer.  The first dietary pattern, High Fat/Meat/Potatoes, was 
similar for Whites and African Americans, while the other two patterns differed slightly.  To 
our knowledge, this is the first study to examine these associations in African Americans. 
Increased consumption of whole grain foods, as well as fruit, vegetables, and dairy 
products, has generally been associated with reduced colon and rectal cancer risk in 
epidemiologic studies (13-15), although results have not been entirely consistent.  The 
potentially protective role of these food groups has been attributed to their fiber content and 
micronutrients such as vitamins, carotenoids, calcium, and folate (16-18).  Our study showed 
that fruit, some vegetables, and dairy foods were associated with reduced risk in Whites.  Our 
findings support evidence from a case-control study by Slattery, et al. that reported 
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significant rectal cancer risk reductions for high consumption of fruit and vegetables in a 
predominantly White population (15).   
 The relationship between fruit and vegetables and rectal cancer risk in our study 
varied by race and food subgroups. Contrary to our results which showed risk reductions 
associated with specific fruits and vegetables among Whites, Michels et al. did not find a 
protective effect for total fruit and vegetable intake, or any subgroups of fruit and vegetables, 
on colon and rectal cancer incidence (19).  High fruit consumption in African Americans 
correlated with significantly higher risk of rectal cancer.  This strong positive association 
remained after adjustment for other dietary variables such as citrus fruit, added sugar, and 
total carbohydrate intake.  The elevated risk may be due to high intakes of high-calorie fruit 
juice or low intakes of fresh fruit. 
 Interestingly, high intake of the red meat in our study population was not significantly 
associated with rectal cancer risk.  It has been hypothesized that the high heme iron content 
in red meat enhances free radical production and tumor cell proliferation (20, 21), and that 
the fat content of red meat may increase the production of bile acids, also causing cellular 
proliferation (22).  Some studies have shown elevated rectal cancer risk to be associated with 
high consumption of red meat (23, 24) and processed meat (24, 25).  Our results are in 
agreement with findings by Wei, et al. which also showed no association between increased 
consumption of red meat and rectal cancer risk (7), although our findings do suggest elevated 
risk for high intake of processed meat in Whites.    
 Fish and other seafood may play an important role in rectal cancer risk reduction 
perhaps due to their rich omega-3 polyunsaturated fatty acid (PUFA) content , which may 
reduce the production of pro-inflammatory eicosanoids (26, 27).  Although the effects of fish 
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and poultry on colon and rectal cancer risk have been examined less often compared to red 
meat, at least five studies have shown fish and poultry to be associated with reduced risk of 
colorectal cancer (23, 24, 28-30).  Three of these studies reported an inverse relationship 
between these food groups and risk of rectal cancer specifically (23, 24, 28), as we did in this 
present study among Whites.  Fish and poultry had a non-significant positive association with 
risk in African Americans, which may reflect how these foods were prepared.  However, the 
results did not change when we adjusted for total fat intake. 
 Three dietary patterns were identified separately among White and African American 
controls using principal components factor analysis.   The High Fat/Meat/Potatoes dietary 
pattern was similar in both race groups. Comparable dietary patterns in some cohort studies 
have found no association of this pattern with colon or rectal cancer risk (31, 32).  However, 
other studies in which this pattern was labeled “Western” and “red meat” have reported 
significant elevated risk of colon cancer and CRC, respectively (4,33). Our results for Whites 
are consistent with these findings because high factor scores among Whites for the High 
Fat/Meat/Potatoes pattern were associated with elevated risk.   
  In addition to a type of “Western” dietary pattern, researchers have often identified a 
presumably healthy pattern that has been labeled “healthy”, “prudent”, and “vegetable” 
patterns in some studies (34-38).  Among Whites in our study, potentially healthy patterns 
emerged as two distinct dietary patterns, i.e. the Veg/Fish/Poultry and the Fruit/Whole Grain 
patterns; both were associated with reduced risk of rectal cancer.  Interestingly, the 
Veg/Fish/Poultry pattern had weak factor loadings for fruits and dairy products, and the 
Fruit/Whole Grain pattern had only weak to modest loadings for most vegetables.  This 
suggests that it may not be appropriate to combine fruit and vegetables as an individual food 
 102
group.  In African Americans, the two presumably healthy patterns were the Fruit/Vegetables 
pattern and the Legumes/Dairy pattern.  There was a positive linear relationship between the 
Fruit/Vegetable pattern and rectal cancer.  This could be due to the heavy loadings of fruit, 
especially citrus fruit, which also showed a significant positive trend in risk in the food group 
analysis.  The Legumes/Dairy pattern in African Americans suggested a protective effect on 
risk, as was expected. 
 These dietary patterns only accounted for 39% and 43% of the total variance in 
Whites and African Americans, respectively, which suggests that other patterns exist.  There 
were a total of 5 factors in Whites and 7 factors in African Americans that had eigenvalues 
greater than 1.0, and together these factors explained 50% and 65% of the variance, 
respectively.  However, these factors not presented were difficult to interpret.  The low 
proportion of variance explained by the 3 factors in race group could also be due, in part, to 
the limited number of foods entered in the factor analysis, or a reflection of the overall 
complexity of the diet. 
 Our findings provide evidence that rectal cancer risk differs between African 
Americans and Whites for certain foods and dietary patterns.  Unfortunately, there are 
virtually no studies of diet and colon and rectal cancer associations in African Americans. 
Similar racial differences were reported by Satia-Abouta, et al. in a population-based study of 
food groups and colon cancer (14).  Few studies have conducted comparisons of dietary 
patterns for Whites and African Americans (39-41).   The dietary patterns in our study were 
similar to those identified in the Multiethnic Cohort Study, which also used the USDA food 
groups for the factor analysis (41).  Bell and colleagues reported that food patterns among 
Whites and African Americans did not differ.  Although the patterns were generally similar 
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in both race groups in our study, there were some different associations with rectal cancer 
risk.  The observed heterogeneity in risk may in part be due to racial variation in dietary 
intake of certain foods and nutrients as reported in some studies (42-44).  We used race-
specific cut-points for food groups and dietary patterns to account for possible differences in 
consumption, although this could have affected our assessment of racial differences in risk.  
We cannot exclude the possibility that socioeconomic status contributes to this racial 
disparity; however, we controlled for both education and income in our analyses. 
 Our study has many strengths, including its population-based design and the inclusion 
of a large number of rectal cancer cases.  Also, the randomized recruitment strategy used to 
select participants minimized the possibility of selection bias in our results.  Over-sampling 
allowed us to increase the number of African Americans in our study sample in an effort to 
assess racial differences.  Both food group analysis and factor analysis were examined in the 
same population and included the same covariates.   
There are also some limitations to our study.  The use of predefined food groups in 
the factor analysis may have introduced error in our risk estimates.  Grouping foods prevents 
the food items within the group from having different loadings on the dietary patterns 
identified and may obscure differences in consumption. However, the consistent use of food 
groupings may enable us to better compare studies of dietary patterns.   Food frequency 
questionnaires, like that used in this study, are subject to measurement error and may not 
have included some typically consumed Southern foods (45) or foods common to certain 
races/ethnicities. Due to our case-control study design, recall bias is a possibility.  Response 
bias may also have been introduced in our study, especially because the response rate was 
lower among African Americans than Whites, and lower among controls compared to cases. 
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Although we over-sampled African Americans, the sample size for this subpopulation was 
relatively small (N=384).  This resulted in less power to detect significant associations in 
African Americans and unstable risk estimates.  Therefore, these findings should be 
interpreted with caution and need to be confirmed in a larger sample of African Americans. 
In summary, this study used two different approaches to investigate the relationship 
between diet and rectal cancer risk: food group analysis and factor analysis.  Our results 
showed that several food groups and dietary patterns are associated with rectal cancer risk. 
Some of the food groups yielded different associations with risk than the overall pattern with 
which it was highly correlated. Complex correlations between foods may be better captured 
by dietary patterns, which may also prove to be more amenable to translation into dietary 
recommendations, and easier to apply to improve the efficacy of nutrition intervention and 
prevention programs.  Notably, our results suggest that dietary risk factors may differ by 
race, which highlights the importance of examining diet and cancer associations in racially 
diverse study populations.   
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F. Tables 
 
Table 10: Characteristics of participants by case/control status and race (North Carolina Colon Cancer 
Study-Phase II) 
 
           Whites (N=1520) 
   Cases (n=720)  Controls (n=800)      
     African Americans (N=384) 
    Cases (n=225) Controls (n=159)       
Sex (%)  
     Male 
                                        
58                      61 
 
                                        
52                     52 
 
Age (years) (%)  
     40-49 
     50-59 
     60-69 
     70-79 
  Mean(SD) 
                                    
19                      12 
28                      27 
32                      34 
22                      27 
59.6(10.3)         61.7(9.8)                      
                                          
21                     18 
29                     23 
34                     42 
16                     18 
58.0(10.0)        60.3(9.8)     
   
Education (%)  
    <=High School 
    Some College 
    College grad/Adv degree 
                                   
50                      39 
25                      26 
25                      35 
                                          
62                     59 
22                     26 
16                     16 
 
Annual Income (%)  
       <$20,000 
         $20,000-$34,999 
         $35,000-$49,999 
         $50,000-$74,999 
       >$75,000 
                                                 
21                       18  
21                       18 
15                       15 
20                       23 
24                       27 
                                                
47                      52 
19                      16 
11                       8 
13                      15 
11                      10 
 
Body Mass Index (1yr ago) (%)  
     Normal (18.5-24.9 kg/m2) 
     Overweight (25.0-29.9 kg/m2) 
     Obese (≥30.0 kg/m2) 
   Mean(SD) 
                                      
23                       30 
39                       41 
39                       29 
29.2(6.3)            28.0(5.5)     
                                          
18                      18 
32                      36 
51                      46 
31.6(7.7)           29.9(6.5)      
 
Smoking Status (%)  
     Current Smoker 
     Former Smoker 
     Never Smoker 
   Mean(SD) years of smoking 
 
Physical activity (MET-min/day*) 
(%) 
     Quartile 1 
     Quartile 2 
     Quartile 3 
     Quartile 4 
Mean(SD) 
 
                                           
16                       14 
47                       49 
37                       38 
26.9(15.6)          25.5(16.7)      
 
 
 
25.4                      24.5 
24.4                      23.5 
21.1                      26.5 
29.1                      25.3 
2250.0(661.8)      2152.7(473.4) 
 
                                           
23                      17 
38                      42 
39                      41 
24.3(16.3)         25.2(17.9)    
 
 
 
30.7                    28.9 
25.5                    28.9 
16.0                    19.5 
27.8                    22.8 
2178.4(545.5)    2152.8(494.2) 
 
NSAID use† (%)  
     Yes 
      
                                   
35                        46 
 
                                          
24                       23 
 
First-degree family history of 
colorectal cancer (%)  
    Yes 
 
                                           
13                         11 
          
 
 
12                        5               
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*Metabolic equivalent minutes per day 
†greater than or equal to 15 non-steroidal anti-inflammatory drugs (NSAID) per month in the past 5 years 
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Table 11:  Odds ratios and 95% confidence intervals for rectal cancer among Whites according to food 
groups (North Carolina Colon Cancer Study-Phase II)* 
 
Food Group 
(servings/week) 
Q1 Q2 Q3 Q4 P  for 
trend 
Total grains 154/202 (20.7)‡ 161/199 (32.3) 181/199  (41.5) 224/200  (60.7)  
OR (95% CI) 1.00 1.09 (0.77-1.55) 1.21 (0.84-1.75) 1.44 (0.92-2.25) 0.09 
Whole grains 204/200  (2.8) 182/203 (6.3) 174/198  (10.2) 160/199  (16.4)  
OR (95% CI) 1.00 1.03 (0.74-1.42) 0.92 (0.66-1.27) 0.93 (0.66-1.31) 0.55 
Non-whole grains 140/200  (14.7) 149/201  (23.6) 200/200  (32.3) 231/199  (48.0)  
OR (95% CI) 1.00 1.19 (0.83-1.71) 1.46 (1.01-2.12) 1.60 (1.01-2.53) 0.04 
Total fruit 243/204  (7.35) 190/201  (14.3) 136/199  (21.0) 151/199  (32.2)  
OR (95% CI) 1.00 0.83 (0.60-1.13) 0.63 (0.45-0.87) 0.62 (0.44-0.86) 0.0021 
Citrus fruit 223/200  (1.89) 218/199  (5.6) 145/201  (9.7) 134/200  (16.4)  
OR (95% CI) 1.00 0.97 (0.71-1.33) 0.71 (0.51-0.99) 0.61 (0.43-0.86) 0.0012 
Other fruit 232/202  (3.01) 161/198  (7.1) 177/200  (11.5) 150/200  (18.5)  
OR (95% CI) 1.00 0.74 (0.54-1.03) 0.83 (0.60-1.14) 0.67 (0.48-0.94) 0.04 
Total vegetables 207/202 (14.7) 186/202  (23.7) 149/165  (31.4) 178/201  (44.6)  
OR (95% CI) 1.00 0.97 (0.70-1.34) 0.76 (0.53-1.09) 0.73 (0.50-1.06) 0.07 
Tomato 197/201  (1.3) 190/205  (2.4) 168/197  (3.6) 165/197  (6.5)  
OR (95% CI) 1.00 1.00 (0.73-1.38) 0.89 (0.63-1.25) 0.86 (0.60-1.23) 0.35 
Dark green vegetables 277/206  (0.6) 173/196  (1.7) 152/198  (3.1) 118/200  (6.4)  
OR (95% CI) 1.00 0.68 (0.50-0.93) 0.59 (0.43-0.81) 0.41 (0.29-0.58) <0.0001 
Deep yellow vegetables 286/229  (0.5) 149/181  (1.0) 148/196  (1.8) 137/194  (3.6)  
OR (95% CI) 1.00 0.72 (0.52-0.99) 0.60 (0.43-0.83) 0.65 (0.46-0.90) 0.02 
Beans and peas 169/179  (0.1) 211/233  (0.6) 176/188  (1.2) 164/200  (2.7)  
OR (95% CI) 1.00 1.02 (0.74-1.41) 0.97 (0.69-1.37) 0.91 (0.64-1.30) 0.52 
White potatoes 112/209  (1.3) 168/198  (3.3) 178/189  (5.6) 262/204  (9.3)  
OR (95% CI) 1.00 1.57 (1.10-2.23) 1.83 (1.27-2.63) 2.55 (1.74-3.73) <0.0001 
Other starchy vegetables 204/204  (0.8) 167/186  (1.8) 185/210  (3.0) 164/200  (5.2)  
OR (95% CI) 1.00 0.77 (0.56-1.07) 0.84 (0.61-1.17) 0.64 (0.45-0.91) 0.026 
Other vegetables 232/204  (5.0) 159/197  (8.3) 173/200  (11.8) 156/199  (18.5)  
OR (95% CI) 1.00 0.76 (0.54-1.05) 0.79 (0.56-1.09) 0.66 (0.47-0.94) 0.04 
Total dairy 203/202  (3.6) 208/201  (6.7) 170/198  (10.9) 139/199  (17.4)  
OR (95% CI) 1.00 0.82 (0.59-1.12) 0.66 (0.47-0.93) 0.47 (0.32-0.69) <0.0001 
Cheese 189/191  (0.6) 208/214  (1.5) 155/194  (2.6) 168/201  (5.9)  
OR (95% CI) 1.00 1.02 (0.74-1.41) 0.69 (0.48-0.99) 0.73 (0.50-1.06) 0.06 
Milk 183/205  (1.4) 190/198  (3.7) 204/197  (6.6) 143/200  (12.7)  
OR (95% CI) 1.00 0.97 (0.70-1.35) 1.02 (0.73-1.42) 0.66 (0.46-0.95) 0.017 
Yogurt 435/430  (0.0) 285/370  (0.42)    
OR (95% CI)† 1.00 0.69 (0.53-0.89)   --- 
Total meat 154/200  (4.2) 208/202  (7.0) 184/198  (10.2) 174/200  (15.7)  
OR (95% CI) 1.00 1.29 (0.92-1.82) 0.97 (0.67-1.40) 0.78 (0.50-1.21) 0.07 
Red meat 148/199  (1.30) 187/203  (2.7) 198/198  (4.4) 187/200  (7.8)  
OR (95% CI) 1.00 1.14 (0.81-1.60) 1.22 (0.85-1.74) 0.85 (0.56-1.28) 0.26 
Organ meat† 380/425  (0.0) 340/375  (0.23)    
OR (95% CI)† 1.00 0.89 (0.70-1.13)   --- 
Processed meat 131/204  (0.3) 178/202  (0.8) 208/198  (1.6) 203/196  (3.1)  
OR (95% CI) 1.00 1.16 (0.82-1.64) 1.45 (1.03-2.05) 1.27 (0.87-1.85) 0.26 
Fish 233/194  (0.3) 194/209  (0.9) 157/197  (1.5) 136/200  (2.7)  
OR (95% CI) 1.00 0.72 (0.53-0.99) 0.68 (0.48-0.94) 0.52 (0.36-0.73) 0.0004 
Poultry 185/202  (0.6) 210/199  (1.3) 175/194  (2.2) 150/205  (4.0)  
OR (95% CI) 1.00 1.15 (0.83-1.59) 0.96 (0.68-1.34) 0.68 (0.47-0.98) 0.01 
Eggs 175/192  (0.6) 175/209  (1.4) 149/202  (2.5) 221/197  (4.2)  
OR (95% CI) 1.00 1.05 (0.75-1.47) 0.81 (0.57-1.14) 1.07 (0.76-1.50) 0.86 
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Table 11 continued 
 
Food Group 
(servings/week) 
Q1 Q2 Q3 Q4 P  for 
trend 
Nuts 192/216  (0.2) 188/189  (0.7) 199/198  (1.5) 141/197  (4.2)  
OR (95% CI) 1.00 1.24 (0.90-1.71) 1.26 (0.90-1.76) 0.92 (0.64-1.32) 0.24 
Soy 558/578  (0.0) 162/222  (0.07)    
OR (95% CI)† 1.00 0.91 (0.70-1.20)   --- 
Added sugar (g) 163/200  (177.5) 144/200 (314.0) 171/200  (489.0) 242/200  (832.7)  
OR (95% CI) 1.00 0.84 (0.60-1.19) 0.90 (0.63-1.28) 1.19 (0.80-1.77) 0.19 
Discretionary fat (g) 146/200  (237.6) 153/200 (373.7) 205/200 (514.2) 216/200 (745.9)  
OR (95% CI) 1.00 0.99 (0.69-1.42) 1.37 (0.92-2.05) 1.32 (0.76-2.28) 0.21 
*adjusted for age, sex, education, income. BMI 1 year ago, physical activity, family history, non-steroidal anti-
inflammatory drug use, and total energy intake  
† OR represents consumers vs. non-consumers (referent) 
‡ number of cases/number of controls (median intake in controls) 
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Table 12: Odds ratios and 95% confidence intervals for rectal cancer among African Americans 
according to food groups (North Carolina Colon Cancer Study-Phase II)* 
 
Food Group 
(servings/week) 
Q1 Q2 Q3 Q4 P  for 
trend 
Total grains 64/40  (20.1)‡ 60/40  (35.5) 44/40  (45.5) 57/39  (65.4)  
OR (95% CI) 1.00 0.70 (0.35-1.41) 0.55 (0.24-1.28) 0.52 (0.19-1.40) 0.19 
Whole grains 72/41  (2.9) 59/40  (6.3) 52/39  (10.6) 42/39  (18.9)  
OR (95% CI) 1.00 1.19 (0.59-2.39) 0.91 (0.45-1.83) 0.67 (0.21-1.42) 0.20 
Non-whole grains 44/40  (14.4) 71/40  (25.7) 49/40 (37.5) 61/39  (53.5)  
OR (95% CI) 1.00 1.18 (0.58-2.43) 0.83 (0.35-2.00) 1.08 (0.37-3.12) 0.99 
Total fruit 42/40  (7.9) 33/40  (13.7) 73/41  (22.8) 77/38  (38.5)  
OR (95% CI) 1.00 0.91 (0.42-1.97) 2.22 (1.05-4.72) 1.90 (0.88-4.10) 0.05 
Citrus fruit 37/40  (2.3) 60/40  (5.7) 57/41  (10.6) 71/38  (21.7)  
OR (95% CI) 1.00 1.97 (0.94-4.17) 1.67 (0.79-6.54) 1.54 (0.71-3.35) 0.68 
Other fruit 41/40  (3.1) 41/39  (7.4) 43/41  (11.7) 100/39  (20.4)  
OR (95% CI) 1.00 1.18 (0.53-2.62) 1.33 (0.61-2.90) 3.25 (1.52-6.96) 0.0004 
Total vegetables 64/40  (11.7) 26/40  (19.3) 60/40  (27.4) 75/39  (45.9)  
OR (95% CI) 1.00 0.36 (0.17-0.79) 0.79 (0.38-1.64) 0.90 (0.40-2.04) 0.58 
Tomato 63/46  (0.6) 55/31  (1.4) 47/43 (2.4) 60/39  (4.2)  
OR (95% CI) 1.00 0.83 (0.40-1.72) 0.58 (0.29-1.19) 0.85 (0.40-1.81) 0.64 
Dark green vegetables 61/40  (0.7) 39/40  (1.8) 50/40  (3.6) 75/39  (8.7)  
OR (95% CI) 1.00 0.54 (0.25-1.15) 0.58 (0.28-1.20) 1.00 (0.48-2.08) 0.42 
Deep yellow vegetables 63/47  (0.3) 45/31  (0.8) 59/42  (1.5) 58/39  (3.4)  
OR (95% CI) 1.00 1.08 (0.52-2.26) 0.72 (0.35-1.48) 0.78 (0.36-1.66) 0.45 
Beans and peas 70/46  (0.1) 71/35  (0.6) 37/39  (1.3) 47/39  (2.6)  
OR (95% CI) 1.00 1.18 (0.60-2.31) 0.57 (0.27-1.17) 0.49 (0.23-1.07) 0.02 
White potatoes 50/41  (1.0) 63/39  (2.8) 45/40  (4.5) 67/39  (8.9)  
OR (95% CI) 1.00 0.96 (0.46-1.99) 0.51 (0.23-1.14) 0.97 (0.42-2.26) 0.89 
Other starchy vegetables 62/40  (0.8) 52/42  (1.5) 43/37  (2.7) 68/40  (5.3)  
OR (95% CI) 1.00 0.94 (0.46-1.94) 0.61 (0.29-1.29) 0.87 (0.40-1.87) 0.75 
Other vegetables 54/42  (3.6) 38/38  (6.5) 60/39  (8.8) 73/40  (17.7)  
OR (95% CI) 1.00 0.39 (0.18-0.82) 0.75 (0.36-1.57) 0.87 (0.39-1.90) 0.66 
Total dairy 37/40  (1.5) 49/40  (3.4) 66/40  (6.8) 73/39  (13.3)  
OR (95% CI) 1.00 0.93 (0.44-1.97) 1.04 (0.47-2.32) 1.18 (0.53-2.62) 0.55 
Cheese 49/36  (0.2) 46/46  (0.8) 68/39  (1.7) 62/38  (4.6)  
OR (95% CI) 1.00 0.633 (0.30-1.31) 0.84 (0.39-1.81) 1.04 (0.44-2.46) 0.50 
Milk 37/36  (0.6) 62/44  (2.1) 60/39  (4.1) 66/40  (8.6)  
OR (95% CI) 1.00 0.94 (0.45-1.96) 0.78  (0.35-1.75) 0.90  (0.41-1.95) 0.85 
Yogurt 142/104  (0.0) 83/55  (0.21)    
OR (95% CI)† 1.00 1.08 (0.62-1.87)   --- 
Total meat 56/40  (4.2) 34/39  (7.0) 78/41  (11.6) 57/39  (18.9)  
OR (95% CI) 1.00 0.42 (0.19-0.92) 1.03 (0.50-2.14) 0.59 (0.22-1.56) 0.65 
Red meat 58/41  (1.0) 39/39  (2.3) 65/39  (3.7) 63/40  (8.8)  
OR (95% CI) 1.00 0.52 (0.25-1.08) 0.97 (0.48-1.97) 0.72 (0.30-1.71) 0.70 
Organ meat 65/56  (0.0) 160/103  (0.09)    
OR (95% CI)† 1.00 1.09 (0.63-1.87)   --- 
Processed meat 44/41  (0.3) 84/38  (1.0) 43/42  (2.0) 54/38  (3.5)  
OR (95% CI) 1.00 1.73 (0.86-3.49) 0.48 (0.21-1.08) 0.89 (0.37-2.11) 0.23 
Fish 43/39  (0.3) 61/41  (0.9) 69/41  (2.0) 52/38  (3.2)  
OR (95% CI) 1.00 1.68 (0.80-3.54) 1.29 (0.62-2.58) 1.14 (0.51-2.54) 0.88 
Poultry 49/40  (0.7) 69/43  (1.7) 52/36  (2.9) 55/40  (5.0)  
OR (95% CI) 1.00 1.27 (0.63-2.55) 1.18 (0.57-2.44) 1.17 (0.53-2.59) 0.82 
Eggs 57/42  (0.7) 45/38  (1.8) 57/40  (3.1) 66/39  (6.6)  
OR (95% CI) 1.00 0.78 (0.38-1.60) 1.18 (0.59-2.35) 1.53 (0.73-3.20) 0.16 
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Table 12 continued 
 
Food Group 
(servings/week) 
Q1 Q2 Q3 Q4 P  for trend 
Nuts 60/41  (0.1) 62/37  (0.4) 36/40  (0.9) 67/41  (2.4)  
OR (95% CI) 1.00 0.90 (0.44-1.81) 0.40 (0.18-0.86) 0.73 (0.34-1.58) 0.57 
Soy 176/128  (0.0) 49/31  (0.04)    
OR (95% CI)† 1.00 0.97 (0.52-1.81)   --- 
Added sugar (g) 38/40  (188.7) 41/39  (351.7) 55/41  (645.1) 91/39  (1036.3)  
OR (95% CI) 1.00 1.20 (0.57-2.50) 1.64 (0.74-3.66) 2.65 (1.11-6.34) 0.02 
Discretionary fat (g) 57/40  (222.5) 42/40  (387.7) 67/40  (551.2) 59/39  (823.2)  
OR (95% CI) 1.00 0.45 (0.21-0.97) 0.51 (0.21-1.25) 0.31 (0.09-1.11) 0.10 
*adjusted for age, sex, education , income, BMI 1 year ago, physical activity, family history, non-steroidal anti-
inflammatory drug use, and total energy intake  
† OR represents consumers vs. non-consumers (referent) 
‡ number of cases/number of controls (median intake in controls) 
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Table 15: Odds ratios and 95% confidence intervals for rectal cancer according to dietary pattern 
quartiles, by race (North Carolina Colon Cancer Study-Phase II)* 
                                                                                       
 
 
Dietary Pattern 
 
 
Q1 
    
 
Q2 
 
 
Q3 
 
 
Q4 
 
 
P  for trend 
      
Whites      
      High fat/Meat/Potatoes      
           Cases/controls 126/200 148/200 221/200 225/200  
           OR (95% CI) 1.00 1.25 (0.86-1.80) 1.80 (1.21-2.68) 1.84 (1.08-3.15) <0.0001 
      Veg/Fish/Poultry      
           Cases/controls 266/200 214/200 118/200 122/200  
           OR (95% CI) 1.00 1.00 (0.74-1.35) 0.57 (0.40-0.80) 0.47 (0.33-0.67) <0.0001 
      Fruit/Whole-grain/Dairy      
           Cases/controls 221/200 196/200 155/200 148/200  
           OR (95% CI) 1.00 1.04 (0.76-1.43) 0.78 (0.56-1.09) 0.65 (0.45-0.93) <0.0001 
      
African Americans      
      High fat/Meat/Potatoes      
           Cases/controls 45/39 59/41 59/39 62/40  
           OR (95% CI) 1.00 0.81 (0.39-1.70) 0.79 (0.33-1.91) 0.89 (0.27-3.00) 0.80 
      Fruit/Vegetables      
           Cases/controls 52/40 37/40 59/39 77/40  
           OR (95% CI) 1.00 0.77 (0.35-1.70) 1.01 (0.49-2.07) 1.50 (0.71-3.18) <0.0001 
      Legumes/Dairy      
           Cases/controls 57/39 46/40 57/41 65/39  
           OR (95% CI) 1.00 0.83 (0.40-1.73) 0.79 (0.39-1.59) 0.74 (0.35-1.59) <0.0001 
*adjusted for age, sex, education , income, BMI 1 year ago, physical activity, family history, non-steroidal anti-
inflammatory drug use, and total energy intake  
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VII. Conclusions 
 
A. Review of aims 
 The overall objective of this dissertation was to investigate the relationship between 
dietary factors and rectal cancer in whites and African Americans in North Carolina.  The 
North Carolina Colon Cancer Study-Phase II was a very appropriate dataset that provided 
extensive information on dietary intake in a racially heterogeneous population in a specific 
geographic area, with a large and fairly equal number of rectal cancer cases and controls.  
The specific aims of this research were to: 1) determine the association between nutrients and 
risk of rectal cancer, 2) determine the association between food groups and risk of rectal 
cancer, and 3) determine the association between dietary patterns and risk of rectal cancer. 
 
B. Summary of findings 
1. Nutrient intake and rectal cancer risk 
a) Micronutrients 
Antioxidants micronutrients (vitamin C, vitamin E, beta-carotene, selenium) had 
significant independent inverse associations with rectal cancer risk in whites, suggesting a 
24-53% reduction in risk.  The combined effect of these antioxidant nutrients in whites was 
associated with a 34% risk reduction (OR: 0.66, 95% CI 0.47-0.91).  With the exception of 
selenium, there were no statistically significant associations in African Americans.  The odds 
ratio for total selenium intake in African Americans was 0.25 (95% CI 0.06-0.68).   
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 High intakes of DNA methylation-related nutrients (folate, vitamin B6, vitamin B12) 
appeared to have a protective effect on rectal cancer in whites, with independent risk 
reductions ranging from 29% to 58%.  The combined effect of these nutrients was also 
associated with lower risk (OR: 0.62, 95% CI 0.44-0.88).  In African Americans, there were 
no statistically significant odds ratios, but we did observe a positive linear trend for vitamin 
B6 intake from food (p<0.0001). 
 For most of the micronutrients, the risk estimates associated with intake from food 
only was more favorable than the risk associated with total intake (i.e. from food and 
supplements).  This finding challenges the notion that supplement use aids in rectal cancer 
risk reduction and supports the idea that adequate intakes from food may be sufficient for 
risk reduction. 
  
b) Macronutrients 
 In regards to macronutrient intake, neither total fat nor any subtypes of fat were 
associated with risk of rectal cancer in whites.  In African Americans, there was a possible 
risk reduction associated with high polyunsaturated fatty acid intake (OR: 0.28, 95% CI 0.08-
0.96).  In whites, absolute intake of protein suggested lower rectal cancer risk, while the risk 
reduction was stronger for the percent of energy from protein (OR: 0.53, 95% CI 0.37-0.77). 
 
2.  Food groups and rectal cancer risk 
 In whites, non-whole (refined) grains and white potatoes were positively associated 
with the risk of rectal cancer.  The following food groups had statistically significant inverse 
associations with risk:  fruit, vegetables (specifically, dark green vegetables, deep yellow 
vegetables, other starchy vegetables (i.e. excluding white potatoes), other vegetables), dairy, 
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fish, and poultry.  In African Americans, other (non-citrus) fruit and added sugar were 
associated with elevated risk, yet no statistically significant risk reductions were observed.  
These findings suggest that there are racial differences in rectal cancer risk associated with 
many of the USDA predefined food groups. 
 
3. Dietary patterns and rectal cancer risk 
 We identified three major dietary patterns among race-specific controls.  In whites, 
the following three patterns emerged: High fat/Meat/Potatoes, Vegetables/Fish/Poultry, and 
Fruit/Whole grain/Dairy.  The High fat/Meat/Potatoes dietary pattern was associated with 
elevated risk of rectal cancer (OR: 1.84, 95% CI 1.08-3.15), while the other two patterns 
were associated with reduced risk.  In African Americans, the following three patterns 
resulted: High fat/Meat/Potatoes, Fruit/Vegetables, and Legumes/Dairy.  There were no 
statistically significant risk estimates observed in African Americans; however, there was a 
positive trend related to the Fruit/Vegetables patterns and there was an inverse trend 
associated with the Legumes/Dairy dietary pattern.  The High fat/Meat/Potatoes pattern in 
both whites and African Americans was highly correlated with total energy (Pearsons’ 
r=0.86 and 0.82, respectively), and inversely correlated with alcohol, folate, and fiber. 
 
 
C. Limitations  
One limitation is the possibility for response bias resulting from those who refuse to 
participate.  The response rate in controls was less than that in cases, and the response rate in 
African Americans was much less than the rate in whites.  Non-responders may be different 
from those who chose to participate, and this could have jeopardized the validity of the study.   
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Recall bias of past exposures is also possible.  Recall bias could also affect these 
analyses if cases recalled their dietary intake differently than controls as a consequence of 
their illness. Dietary information was limited to the one year prior to interview or diagnosis.  
This short interval helped to limit recall errors.  Cases were interviewed well after they 
recovered from surgery in an effort to minimize differential recall. Although diet in the more 
distant past may be more relevant to cancer development, there is greater potential for 
inaccurate recall when assessing diet in the remote past.  
Measurement error was also possible due to the use of a food frequency 
questionnaire, such as the Diet History Questionnaire (DHQ), and the nutrient databases.  
Possibly, this error was reduced by using trained nurse-interviewers, in an attempt to 
standardize the way the questions were asked and interpreted.  It is important to note that 
measurement error from food frequency questionnaires usually attenuates estimates of 
disease risk.  Also, it is possible that the DHQ possibly did not include certain food items 
common to certain race/ethnic groups or southern diets.   
Another limitation is that we had a small sample of African Americans, despite our 
efforts to over-sample and increase their representation in the study.  This could have 
prevented us from observing more statistically significant results, thereby limiting our ability 
to accurately assess racial differences in risk. 
 
D. Strengths 
The major strength of this study is that it is one of the first studies to examine the association 
of dietary factors and rectal cancer risk in a large sample of African-Americans and Whites 
recruited from the same geographic area.  This will enable us to observe associations that 
may not have been detectable in smaller studies.  It will further allow us to assess possible 
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racial differences in risk for rectal cancer, for which there is currently no evidence. The case-
control study design is useful for exploring exposure-disease relationships when the disease 
is rare and/or has a long latency period, such as cancer.  The population-based feature of our 
study improves the generalizability of our findings and the randomized recruitment feature 
minimized potential selection bias. 
 
E. Public health significance 
 Colorectal cancer (CRC) is the fourth most common cancer in the U.S.  Rectal cancer 
accounts for approximately one-third of all colorectal cancers.  Diet plays a major role in 
CRC development because everything we consume comes in contact with the lining of the 
colon and rectum to some extent.  While there is abundant evidence regarding the effect of 
diet on colorectal and colon cancer, much less is known about the relationship between 
dietary factors and risk of rectal cancer.  In addition, African Americans have the highest 
incidence and mortality of colon and rectal cancer.  While some of this disparity is due to 
socioeconomic status and access to care, these factors do not fully explain why African 
Americans are disproportionately affected by CRC.  Nationally representative data has 
shown that dietary intake differs between whites and African Americans; therefore, it is 
logical to assume that differences in consumption may correlate with differences in risk.  It 
was important to investigate this possibility since colon and rectal cancers are partially 
preventable by dietary modifications.  
 This dissertation supports the hypothesis that there are some differences in dietary 
intake and risk associated with rectal cancer between whites and African Americans, which 
may contribute to racial disparities.  It further emphasizes the need to examine diet-cancer 
associations in large racially diverse samples to confirm (or dispute) these findings.  This 
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study adds to the literature on the epidemiology and etiology of rectal cancer, especially in 
African Americans.  Because some of the associations we observed for rectal cancer in this 
study contradict what has been suggested for colon cancer, this stresses the importance of 
examining these carcinomas separately when trying to identify risk factors. 
 
 
